Calcium-dependent	O
immediate-early	B-DNA
gene	I-DNA
induction	O
in	O
lymphocytes	B-cell_type
is	O
negatively	O
regulated	O
by	O
p21Ha-ras	B-protein
.	O

The	O
induction	O
of	O
immediate-early	B-DNA
(	I-DNA
IE	I-DNA
)	I-DNA
response	I-DNA
genes	I-DNA
,	O
such	O
as	O
egr-1	B-DNA
,	O
c-fos	B-DNA
,	O
and	O
c-jun	B-DNA
,	O
occurs	O
rapidly	O
after	O
the	O
activation	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

The	O
process	O
of	O
activation	O
involves	O
calcium	O
mobilization	O
,	O
activation	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
,	O
and	O
phosphorylation	O
of	O
tyrosine	B-protein
kinases	I-protein
.	O

p21	B-protein
(	I-protein
ras	I-protein
)	I-protein
,	O
a	O
guanine	B-protein
nucleotide	I-protein
binding	I-protein
factor	I-protein
,	O
mediates	O
T-cell	O
signal	O
transduction	O
through	O
PKC	B-protein
-dependent	O
and	O
PKC	B-protein
-independent	O
pathways	O
.	O

The	O
involvement	O
of	O
p21	B-protein
(	I-protein
ras	I-protein
)	I-protein
in	O
the	O
regulation	O
of	O
calcium-dependent	O
signals	O
has	O
been	O
suggested	O
through	O
analysis	O
of	O
its	O
role	O
in	O
the	O
activation	O
of	O
NF-AT	B-protein
.	O

We	O
have	O
investigated	O
the	O
inductions	O
of	O
the	O
IE	B-DNA
genes	I-DNA
in	O
response	O
to	O
calcium	O
signals	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
(	O
in	O
the	O
presence	O
of	O
activated	O
p21	B-protein
(	I-protein
ras	I-protein
)	I-protein
)	O
and	O
their	O
correlated	O
consequences	O
.	O

The	O
expression	O
of	O
activated	O
p21	B-protein
(	I-protein
ras	I-protein
)	I-protein
negatively	O
regulated	O
the	O
induction	O
of	O
IE	B-DNA
genes	I-DNA
by	O
calcium	O
ionophore	O
.	O

This	O
inhibition	O
of	O
calcium-activated	O
IE	B-DNA
gene	I-DNA
induction	O
was	O
reversed	O
by	O
treatment	O
with	O
cyclosporin	O
A	O
,	O
suggesting	O
the	O
involvement	O
of	O
calcineurin	B-protein
in	O
this	O
regulation	O
.	O

A	O
later	O
result	O
of	O
inhibition	O
of	O
this	O
activation	O
pathway	O
by	O
p21	B-protein
(	I-protein
ras	I-protein
)	I-protein
was	O
down-regulation	O
of	O
the	O
activity	O
of	O
the	O
transcription	B-protein
factor	I-protein
AP-1	B-protein
and	O
subsequent	O
coordinate	O
reductions	O
in	O
IL-2	B-DNA
gene	I-DNA
expression	O
and	O
protein	O
production	O
.	O

These	O
results	O
suggest	O
that	O
p2l	B-protein
(	I-protein
ras	I-protein
)	I-protein
is	O
an	O
essential	O
mediator	O
in	O
generating	O
not	O
only	O
positive	O
but	O
also	O
negative	O
modulatory	O
mechanisms	O
controlling	O
the	O
competence	O
of	O
T	B-cell_type
cells	I-cell_type
in	O
response	O
to	O
inductive	O
stimulations	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Nov.	NULL
1996	NULL
,	NULL
p.	NULL
6582-6592	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Calcium-Dependent	NULL
Immediate-Early	NULL
Gene	NULL
Induction	NULL
in	NULL
Lymphocytes	NULL
Is	NULL
Negatively	NULL
Regulated	NULL
by	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
*	NULL
CHANG-YAN	NULL
CHEN	NULL
,	NULL
LORA	NULL
W.	NULL
FORMAN	NULL
,	NULL
anp	NULL
DOUGLAS	NULL
V.	NULL
FALLER*	NULL
Cancer	NULL
Research	NULL
Center	NULL
and	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Biochemistry	NULL
,	NULL
Boston	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02118	NULL
Received	NULL
23	NULL
February	NULL
1996/Returned	NULL
for	NULL
modification	NULL
15	NULL
April	NULL
1996/Accepted	NULL
7	NULL
August	NULL
1996	NULL
The	NULL
induction	NULL
of	NULL
immediate-early	NULL
(	NULL
IE	NULL
)	NULL
response	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
egr-1	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
c-jun	NULL
,	NULL
occurs	NULL
rapidly	NULL
after	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
process	NULL
of	NULL
activation	NULL
involves	NULL
calcium	NULL
mobilization	NULL
,	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
.	NULL

p21	NULL
``	NULL
,	NULL
a	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
factor	NULL
,	NULL
mediates	NULL
T-cell	NULL
signal	NULL
transduction	NULL
through	NULL
PKC-dependent	NULL
and	NULL
PKC-independent	NULL
pathways	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
calcium-dependent	NULL
signals	NULL
has	NULL
been	NULL
suggested	NULL
through	NULL
analysis	NULL
of	NULL
its	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-AT	NULL
.	NULL

We	NULL
have	NULL
investigated	NULL
the	NULL
inductions	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
in	NULL
response	NULL
to	NULL
calcium	NULL
signals	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
activated	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
)	NULL
and	NULL
their	NULL
correlated	NULL
consequences	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
activated	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
negatively	NULL
regulated	NULL
the	NULL
induction	NULL
of	NULL
IE	NULL
genes	NULL
by	NULL
calcium	NULL
ionophore	NULL
.	NULL

This	NULL
inhibition	NULL
of	NULL
calcium-activated	NULL
IE	NULL
gene	NULL
induction	NULL
was	NULL
reversed	NULL
by	NULL
treatment	NULL
with	NULL
cyclosporin	NULL
A	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
calcineurin	NULL
in	NULL
this	NULL
regulation	NULL
.	NULL

A	NULL
later	NULL
result	NULL
of	NULL
inhibition	NULL
of	NULL
this	NULL
activation	NULL
pathway	NULL
by	NULL
p21	NULL
``	NULL
was	NULL
down-regulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
and	NULL
subsequent	NULL
coordinate	NULL
reductions	NULL
in	NULL
ZL-2	NULL
gene	NULL
expression	NULL
and	NULL
protein	NULL
production	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
is	NULL
an	NULL
essential	NULL
mediator	NULL
in	NULL
generating	NULL
not	NULL
only	NULL
positive	NULL
but	NULL
also	NULL
negative	NULL
modulatory	NULL
mechanisms	NULL
controlling	NULL
the	NULL
competence	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
inductive	NULL
stimulations	NULL
.	NULL

Cells	NULL
modulate	NULL
incoming	NULL
environmental	NULL
signals	NULL
from	NULL
the	NULL
environment	NULL
,	NULL
often	NULL
via	NULL
receptor-ligand	NULL
interactions	NULL
,	NULL
and	NULL
integrate	NULL
positive	NULL
and	NULL
negative	NULL
stimuli	NULL
in	NULL
such	NULL
a	NULL
way	NULL
that	NULL
the	NULL
cellular	NULL
response	NULL
can	NULL
be	NULL
modulated	NULL
in	NULL
both	NULL
magnitude	NULL
and	NULL
duration	NULL
.	NULL

Signals	NULL
initiating	NULL
at	NULL
the	NULL
cell	NULL
membrane	NULL
are	NULL
transduced	NULL
to	NULL
the	NULL
nucleus	NULL
through	NULL
a	NULL
variety	NULL
of	NULL
parallel	NULL
and	NULL
sometimes	NULL
interacting	NULL
cytoplasmic	NULL
second	NULL
messengers	NULL
.	NULL

One	NULL
type	NULL
of	NULL
target	NULL
for	NULL
these	NULL
signaling	NULL
events	NULL
,	NULL
the	NULL
transcription	NULL
factors	NULL
,	NULL
can	NULL
themselves	NULL
be	NULL
activating	NULL
or	NULL
inhibitory	NULL
and	NULL
individually	NULL
,	NULL
or	NULL
in	NULL
concert	NULL
,	NULL
can	NULL
further	NULL
integrate	NULL
the	NULL
variety	NULL
of	NULL
signals	NULL
impinging	NULL
upon	NULL
them	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
coordinated	NULL
interactions	NULL
between	NULL
multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
and	NULL
transcription	NULL
factors	NULL
result	NULL
in	NULL
specific	NULL
biological	NULL
programs	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
activation	NULL
events	NULL
resulting	NULL
from	NULL
mito-gen	NULL
stimulation	NULL
or	NULL
cross-linking	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TcR	NULL
)	NULL
-CD3	NULL
complex	NULL
include	NULL
phospholipid	NULL
hydrolysis	NULL
,	NULL
with	NULL
subsequent	NULL
increases	NULL
in	NULL
calcium	NULL
mobilization	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
activation	NULL
,	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
4	NULL
,	NULL
23	NULL
,	NULL
24	NULL
,	NULL
44	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Following	NULL
these	NULL
immediate	NULL
signaling	NULL
consequences	NULL
of	NULL
TcR	NULL
triggering	NULL
,	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
activity	NULL
is	NULL
rapidly	NULL
stimulated	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
its	NULL
conversion	NULL
from	NULL
the	NULL
GDP-	NULL
to	NULL
the	NULL
GTP-bound	NULL
state	NULL
(	NULL
19	NULL
,	NULL
28	NULL
,	NULL
29	NULL
,	NULL
35	NULL
)	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
two	NULL
mechanisms	NULL
,	NULL
acting	NULL
through	NULL
PKC-dependent	NULL
and	NULL
PKC-independent	NULL
pathways	NULL
,	NULL
which	NULL
are	NULL
responsible	NULL
for	NULL
p21	NULL
``	NULL
regulation	NULL
(	NULL
35	NULL
,	NULL
88	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
p21	NULL
``	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
calcium-mediated	NULL
arm	NULL
of	NULL
the	NULL
T-cell	NULL
activation	NULL
pathway	NULL
and	NULL
may	NULL
cooperate	NULL
with	NULL
calcineurin	NULL
,	NULL
a	NULL
calcium-dependent	NULL
protein	NULL
phosphatase	NULL
(	NULL
PP2B	NULL
)	NULL
,	NULL
to	NULL
regulate	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
,	NULL
an	NULL
important	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
induction	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
11a	NULL
)	NULL
.	NULL

After	NULL
the	NULL
activation	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
``	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
numerous	NULL
regulators	NULL
,	NULL
including	NULL
Raf	NULL
,	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinases	NULL
,	NULL
and	NULL
the	NULL
extracellular	NULL
signal-regulated	NULL
MAP	NULL
kinases	NULL
(	NULL
ERKs	NULL
)	NULL
,	NULL
are	NULL
induced	NULL
(	NULL
34	NULL
,	NULL
46	NULL
,	NULL
77	NULL
,	NULL
81	NULL
,	NULL
86	NULL
)	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Boston	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
80	NULL
E.	NULL
Concord	NULL
St.	NULL
E-124	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02118	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
617	NULL
)	NULL
638-4173	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
617	NULL
)	NULL
638-4176	NULL
.	NULL

6582	NULL
In	NULL
response	NULL
to	NULL
membrane-generated	NULL
signals	NULL
,	NULL
several	NULL
distinct	NULL
nuclear	NULL
events	NULL
also	NULL
occur	NULL
in	NULL
appropriate	NULL
spatial	NULL
and	NULL
temporal	NULL
orders	NULL
:	NULL
the	NULL
induction	NULL
of	NULL
immediate-early	NULL
(	NULL
IE	NULL
)	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
egr-1	NULL
,	NULL
and	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
genes	NULL
;	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
through	NULL
regulation	NULL
by	NULL
transcription	NULL
factors	NULL
NF-AT	NULL
,	NULL
NF-kB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
Oct-1	NULL
;	NULL
and	NULL
the	NULL
final	NULL
mitogenic	NULL
response	NULL
via	NULL
the	NULL
binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
cognate	NULL
receptor	NULL
.	NULL

It	NULL
is	NULL
not	NULL
fully	NULL
understood	NULL
,	NULL
however	NULL
,	NULL
how	NULL
these	NULL
different	NULL
signals	NULL
are	NULL
modulated	NULL
and	NULL
integrated	NULL
into	NULL
a	NULL
genetic	NULL
pathway	NULL
by	NULL
epis-tasis	NULL
,	NULL
interact	NULL
or	NULL
form	NULL
complexes	NULL
with	NULL
each	NULL
other	NULL
,	NULL
and	NULL
terminate	NULL
after	NULL
a	NULL
precise	NULL
time	NULL
interval	NULL
.	NULL

The	NULL
IE	NULL
genes	NULL
c-fos	NULL
,	NULL
egr-1	NULL
,	NULL
and	NULL
c-jun	NULL
are	NULL
rapidly	NULL
and	NULL
transiently	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
environmental	NULL
stimuli	NULL
(	NULL
17	NULL
,	NULL
41	NULL
,	NULL
47	NULL
,	NULL
50	NULL
,	NULL
76	NULL
,	NULL
79	NULL
)	NULL
.	NULL

The	NULL
rapid	NULL
transactivation	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
,	NULL
and	NULL
its	NULL
induction	NULL
is	NULL
mediated	NULL
by	NULL
discrete	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
SRF	NULL
,	NULL
Elk-1	NULL
,	NULL
and	NULL
CREB	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
and	NULL
stimuli	NULL
delivered	NULL
(	NULL
32	NULL
,	NULL
67	NULL
,	NULL
72	NULL
,	NULL
73	NULL
,	NULL
78	NULL
)	NULL
.	NULL

In	NULL
fibroblasts	NULL
,	NULL
serum	NULL
stimulation	NULL
mediating	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
SRF-Elk-1	NULL
complex	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
p21	NULL
``	NULL
``	NULL
-dependent	NULL
kinase	NULL
cascade	NULL
,	NULL
involving	NULL
,	NULL
sequentially	NULL
,	NULL
Raf	NULL
,	NULL
MAP	NULL
kinase	NULL
,	NULL
and	NULL
pp90*	NULL
(	NULL
7	NULL
,	NULL
12	NULL
,	NULL
27	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Calcium	NULL
stimulation	NULL
activates	NULL
SRF	NULL
and	NULL
CREB	NULL
through	NULL
an	NULL
Ras-independent	NULL
mechanism	NULL
involved	NULL
in	NULL
a	NULL
calmodulin	NULL
kinase	NULL
(	NULL
56	NULL
,	NULL
58	NULL
,	NULL
67	NULL
,	NULL
69	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
egr-7	NULL
is	NULL
induced	NULL
shortly	NULL
after	NULL
mitogenic	NULL
stimulation	NULL
in	NULL
cells	NULL
of	NULL
most	NULL
lineages	NULL
and	NULL
generally	NULL
parallels	NULL
the	NULL
pattern	NULL
observed	NULL
for	NULL
c-fos	NULL
(	NULL
76	NULL
)	NULL
.	NULL

The	NULL
coregulation	NULL
c-fos	NULL
and	NULL
egr-1	NULL
can	NULL
be	NULL
explained	NULL
,	NULL
to	NULL
some	NULL
extent	NULL
,	NULL
by	NULL
the	NULL
elements	NULL
common	NULL
to	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
genes	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
by	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
Jun	NULL
N-terminal	NULL
protein	NULL
kinase	NULL
JNK	NULL
,	NULL
in	NULL
an	NULL
Ras-depen-dent	NULL
fashion	NULL
(	NULL
18	NULL
,	NULL
75	NULL
)	NULL
.	NULL

In	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
transcription	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
may	NULL
be	NULL
controlled	NULL
by	NULL
a	NULL
calcium-regulated	NULL
,	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
-sensitive	NULL
signaling	NULL
pathway	NULL
(	NULL
79	NULL
)	NULL
.	NULL

Despite	NULL
a	NULL
great	NULL
deal	NULL
of	NULL
progress	NULL
in	NULL
identifying	NULL
and	NULL
characterizing	NULL
the	NULL
signal	NULL
transducers	NULL
that	NULL
positively	NULL
regulate	NULL
IE	NULL
gene	NULL
transcription	NULL
(	NULL
18	NULL
,	NULL
50	NULL
,	NULL
69	NULL
,	NULL
73	NULL
)	NULL
,	NULL
much	NULL
less	NULL
is	NULL
known	NULL
about	NULL
negative	NULL
regulatory	NULL
mechanisms	NULL
which	NULL
modulate	NULL
and	NULL
attenuate	NULL
the	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
signals	NULL
to	NULL
achieve	NULL
an	NULL
appropriately	NULL
timed	NULL
transcriptional	NULL
or	NULL
biological	NULL
response	NULL
.	NULL

Specifically	NULL
,	NULL
potential	NULL
cross-talk	NULL
between	NULL
the	NULL
p21	NULL
``	NULL
``	NULL
-mediated	NULL
and	NULL
calcium-activated	NULL
pathways	NULL
regulating	NULL
IE	NULL
gene	NULL
expression	NULL
in	NULL
lymphocytes	NULL
has	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

To	NULL
study	NULL
this	NULL
issue	NULL
,	NULL
a	NULL
constitutively	NULL
activated	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
gene	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
was	NULL
stably	NULL
transfected	NULL
into	NULL
a	NULL
human	NULL
T-lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
the	NULL
response	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
to	NULL
stimulation	NULL
with	NULL
calcium	NULL
ionophore	NULL
was	NULL
examined	NULL
.	NULL

Here	NULL
we	NULL
present	NULL
biochemical	NULL
evidence	NULL
that	NULL
activated	NULL
p21	NULL
``	NULL
negatively	NULL
regulates	NULL
the	NULL
calcium-mediated	NULL
induction	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
egr-1	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
c-jun	NULL
and	NULL
subsequently	NULL
down-regulates	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
transcription	NULL
factor	NULL
AP-1	NULL
and	NULL
IL-2	NULL
production	NULL
.	NULL

The	NULL
negative	NULL
effect	NULL
of	NULL
p21	NULL
``	NULL
on	NULL
egr-1	NULL
and	NULL
fos	NULL
gene	NULL
induction	NULL
by	NULL
calcium	NULL
can	NULL
be	NULL
abolished	NULL
by	NULL
pretreatment	NULL
with	NULL
CsA	NULL
,	NULL
a	NULL
calcineurin	NULL
inhibitor	NULL
.	NULL

Expression	NULL
of	NULL
activated	NULL
p21	NULL
``	NULL
``	NULL
can	NULL
also	NULL
inhibit	NULL
calcium-mediated	NULL
c-jun	NULL
induction	NULL
,	NULL
but	NULL
this	NULL
inhibition	NULL
can	NULL
not	NULL
be	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
p21	NULL
``	NULL
,	NULL
as	NULL
an	NULL
important	NULL
signal	NULL
transducer	NULL
,	NULL
not	NULL
only	NULL
mediates	NULL
mitogenic	NULL
signaling	NULL
but	NULL
also	NULL
functions	NULL
as	NULL
an	NULL
inhibitor	NULL
,	NULL
in	NULL
a	NULL
negative	NULL
and	NULL
calcium-dependent	NULL
fashion	NULL
,	NULL
to	NULL
regulate	NULL
a	NULL
precise	NULL
biological	NULL
response	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
cell	NULL
transfections	NULL
.	NULL

The	NULL
human	NULL
T-lymphoid	NULL
cell	NULL
line	NULL
Jurkat	NULL
(	NULL
American	NULL
Tissue	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

was	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
newborn	NULL
calf	NULL
serum	NULL
(	NULL
Hazelton	NULL
Research	NULL
Products	NULL
,	NULL
Inc.	NULL
,	NULL
Lenexa	NULL
,	NULL
Kans	NULL
.	NULL
)	NULL

,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
stably	NULL
transfected	NULL
by	NULL
electroporation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
v-Ha-ras-ex-pressing	NULL
vector	NULL
PH1	NULL
,	NULL
a	NULL
circularly	NULL
permuted	NULL
clone	NULL
of	NULL
the	NULL
Harvey	NULL
sarcoma	NULL
virus	NULL
,	NULL
was	NULL
the	NULL
gift	NULL
of	NULL
E.	NULL
Scolnick	NULL
,	NULL
Merck	NULL
Pharmaceuticals	NULL
.	NULL

This	NULL
gene	NULL
was	NULL
cotransfected	NULL
with	NULL
a	NULL
selectable	NULL
marker	NULL
conferring	NULL
resistance	NULL
to	NULL
geneticin	NULL
(	NULL
G418	NULL
;	NULL
Gibco	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
transfectants	NULL
were	NULL
subcloned	NULL
and	NULL
selected	NULL
for	NULL
resistance	NULL
to	NULL
G418	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
v-ras	NULL
transcript	NULL
and	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
protein	NULL
levels	NULL
for	NULL
each	NULL
subclone	NULL
were	NULL
quantitated	NULL
by	NULL
RNA	NULL
blotting	NULL
and	NULL
immunoblotting	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
one	NULL
representative	NULL
subclone	NULL
(	NULL
number	NULL
7	NULL
)	NULL
,	NULL
which	NULL
expresses	NULL
relatively	NULL
high	NULL
levels	NULL
of	NULL
v-ras	NULL
mRNA	NULL
,	NULL
was	NULL
used	NULL
throughout	NULL
the	NULL
experiments	NULL
presented	NULL
here	NULL
.	NULL

The	NULL
results	NULL
found	NULL
with	NULL
this	NULL
clone	NULL
were	NULL
representative	NULL
of	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
other	NULL
independently	NULL
derived	NULL
lines	NULL
,	NULL
which	NULL
expressed	NULL
different	NULL
levels	NULL
of	NULL
v-res	NULL
transcripts	NULL
and	NULL
protein	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
clone	NULL
19	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Full	NULL
characterization	NULL
of	NULL
the	NULL
Ras	NULL
transcript	NULL
and	NULL
protein	NULL
expression	NULL
of	NULL
these	NULL
clones	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
11a	NULL
)	NULL
.	NULL

As	NULL
controls	NULL
for	NULL
the	NULL
transfection	NULL
and	NULL
selection	NULL
processes	NULL
,	NULL
some	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
only	NULL
with	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
,	NULL
designated	NULL
neo	NULL
,	NULL
and	NULL
used	NULL
in	NULL
the	NULL
studies	NULL
described	NULL
below	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
res	NULL
transfectants	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
carried	NULL
in	NULL
the	NULL
same	NULL
growth	NULL
medium	NULL
plus	NULL
0.7	NULL
mg	NULL
of	NULL
G418	NULL
per	NULL
ml	NULL
.	NULL

For	NULL
studies	NULL
of	NULL
calcium	NULL
mobilization	NULL
,	NULL
cells	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
,	NULL
resuspended	NULL
at	NULL
10Â°	NULL
cells/ml	NULL
in	NULL
a	NULL
buffered	NULL
salt	NULL
solution	NULL
containing	NULL
glucose	NULL
and	NULL
1.	NULL
mM	NULL
1-	NULL
[	NULL
2-amino-5-	NULL
(	NULL
6-carboxyindol-2-yl	NULL
)	NULL
phenoxy	NULL
]	NULL
-2-	NULL
(	NULL
2'-amino-5	NULL
'	NULL
-methyl-phenoxy	NULL
)	NULL
ethane-N	NULL
,	NULL
N	NULL
,	NULL
V	NULL
'	NULL
,	NULL
V	NULL
'	NULL
-tetraacetic	NULL
acid	NULL
sodium	NULL
(	NULL
INDO-1	NULL
)	NULL
,	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
to	NULL
allow	NULL
uptake	NULL
of	NULL
the	NULL
INDO-1	NULL
,	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
50	NULL
volumes	NULL
of	NULL
balanced	NULL
salt	NULL
solution	NULL
to	NULL
remove	NULL
excess	NULL
dye	NULL
.	NULL

Calcium	NULL
mobilization	NULL
in	NULL
response	NULL
to	NULL
ionophore	NULL
was	NULL
then	NULL
determined	NULL
with	NULL
a	NULL
stirred	NULL
cuvette	NULL
at	NULL
37Â°C	NULL
in	NULL
an	NULL
Aminco-Bowman	NULL
fluorimeter	NULL
with	NULL
real-time	NULL
recording	NULL
at	NULL
405	NULL
and	NULL
480	NULL
nm	NULL
.	NULL

RNA	NULL
blot	NULL
analysis	NULL
.	NULL

After	NULL
subjecting	NULL
the	NULL
cells	NULL
to	NULL
different	NULL
stimuli	NULL
,	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
guanidine	NULL
thiocyanate-phenol	NULL
RNA	NULL
extraction	NULL
,	NULL
quantified	NULL
,	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
formaldehyde	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Hybridizations	NULL
and	NULL
high-stringency	NULL
washes	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

*Â°P-labeled	NULL
DNA	NULL
probes	NULL
were	NULL
generated	NULL
by	NULL
the	NULL
random	NULL
oligonucleotide	NULL
primer	NULL
method	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
egr-7	NULL
probe	NULL
was	NULL
a	NULL
1.6-kb	NULL
Bg/II	NULL
fragment	NULL
of	NULL
murine	NULL
egr-7	NULL
cDNA	NULL
(	NULL
generously	NULL
provided	NULL
by	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
)	NULL
.	NULL

The	NULL
fos	NULL
probe	NULL
was	NULL
a	NULL
1.1-kb	NULL
EcoRI-Sell	NULL
fragment	NULL
of	NULL
the	NULL
murine	NULL
Â¢-fos	NULL
cDNA	NULL
.	NULL

The	NULL
c-jun	NULL
probe	NULL
was	NULL
a	NULL
1.7-kb	NULL
Psfl	NULL
fragment	NULL
of	NULL
the	NULL
murine	NULL
c-jun	NULL
cDNA	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
concentrations	NULL
of	NULL
the	NULL
reagents	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
200	NULL
ng	NULL
of	NULL
CsA	NULL
(	NULL
gift	NULL
of	NULL
Sandoz	NULL
Pharmaceuticals	NULL
,	NULL
East	NULL
Hanover	NULL
,	NULL
N.J.	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
5	NULL
ng	NULL
of	NULL
sirolimus	NULL
per	NULL
ml	NULL
,	NULL
1.5	NULL
M	NULL
calmodulin	NULL
kinase	NULL
inhibitor	NULL
(	NULL
Sigma	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

,	NULL
and	NULL
10	NULL
M	NULL
forskolin	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
these	NULL
reagents	NULL
,	NULL
at	NULL
the	NULL
concentrations	NULL
and	NULL
exposure	NULL
times	NULL
used	NULL
herein	NULL
,	NULL
have	NULL
the	NULL
desired	NULL
effects	NULL
of	NULL
inhibiting	NULL
NF-AT	NULL
and	NULL
IL-2	NULL
induction	NULL
,	NULL
inhibiting	NULL
S6	NULL
kinase	NULL
activity	NULL
,	NULL
inhibiting	NULL
calmodulin	NULL
kinase	NULL
activity	NULL
,	NULL
or	NULL
stimulating	NULL
PKA	NULL
.	NULL

Each	NULL
inhibitor	NULL
was	NULL
added	NULL
into	NULL
the	NULL
medium	NULL
of	NULL
cell	NULL
cultures	NULL
10	NULL
min	NULL
before	NULL
further	NULL
stimulation	NULL
.	NULL

For	NULL
the	NULL
IL-2	NULL
gene	NULL
expression	NULL
experiment	NULL
,	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
was	NULL
isolated	NULL
with	NULL
a	NULL
FastTrack	NULL
kit	NULL
,	NULL
version	NULL
2.0	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
probe	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
as	NULL
a	NULL
200-bp	NULL
DNA	NULL
fragment	NULL
.	NULL

Plasmids	NULL
and	NULL
transient	NULL
transfections	NULL
.	NULL

The	NULL
vector	NULL
p6O0O0cat3	NULL
contains	NULL
the	NULL
chlor-amphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
600	NULL
bp	NULL
of	NULL
the	NULL
murine	NULL
c-fos	NULL
gene	NULL
promoter	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
R.	NULL
Muller	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
20	NULL
x	NULL
10Â°	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
960	NULL
mF	NULL
;	NULL
250	NULL
V	NULL
)	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
reporter	NULL
NEGATIVE	NULL
REGULATION	NULL
OF	NULL
IE	NULL
GENE	NULL
EXPRESSION	NULL
BY	NULL
Ras	NULL
6583	NULL
plasmid	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
several	NULL
aliquots	NULL
for	NULL
stimulation	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
.	NULL

Cotransfections	NULL
with	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
B-galactosidase	NULL
vector	NULL
were	NULL
used	NULL
to	NULL
verify	NULL
equivalent	NULL
efficiencies	NULL
of	NULL
transfection	NULL
.	NULL

Following	NULL
4	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
25	NULL
mM	NULL
Tris	NULL
buffer	NULL
and	NULL
an	NULL
assay	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
conducted	NULL
with	NULL
an	NULL
organic	NULL
extraction	NULL
to	NULL
separate	NULL
the	NULL
acetylated	NULL
products	NULL
;	NULL
the	NULL
assay	NULL
was	NULL
followed	NULL
by	NULL
quantitation	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
rather	NULL
than	NULL
organic	NULL
extraction	NULL
.	NULL

Immunoblotting	NULL
.	NULL

Cells	NULL
(	NULL
20	NULL
X	NULL
10Â°	NULL
per	NULL
treatment	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
as	NULL
described	NULL
for	NULL
the	NULL
MAP	NULL
kinase	NULL
assay	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
100	NULL
pg	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
acrylamide	NULL
gel	NULL
and	NULL
subsequently	NULL
immunoblotted	NULL
with	NULL
either	NULL
anti-PKCo	NULL
or	NULL
anti-PKCB	NULL
antibodies	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
Ky.	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
developed	NULL
with	NULL
an	NULL
anti-mouse	NULL
immunoglobulin	NULL
alkaline	NULL
phosphatase	NULL
reagent	NULL
(	NULL
Oncogene	NULL
Science	NULL
,	NULL
Uniondale	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

Phosphorylation	NULL
analyses	NULL
and	NULL
immunoprecipitations	NULL
.	NULL

Cells	NULL
(	NULL
50	NULL
X	NULL
10Â°	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
1	NULL
%	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
permeabilization	NULL
medium	NULL
containing	NULL
0.6	NULL
IU	NULL
of	NULL
streptolysin	NULL
O	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
mM	NULL
PIPES	NULL
[	NULL
piperazine-N	NULL
,	NULL
NV	NULL
'	NULL
-bis	NULL
(	NULL
2-ethanesulfonic	NULL
acid	NULL
)	NULL
,	NULL
pH	NULL
7.2	NULL
]	NULL
,	NULL
120	NULL
mM	NULL
KCI	NULL
,	NULL
30	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
100	NULL
nM	NULL
CaCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
ATP	NULL
,	NULL
and	NULL
5	NULL
Ci	NULL
of	NULL
[	NULL
Â«	NULL
-P	NULL
]	NULL
JATP	NULL
.	NULL

The	NULL
stimuli	NULL
were	NULL
added	NULL
simultaneously	NULL
.	NULL

The	NULL
optimum	NULL
streptolysin	NULL
O	NULL
(	NULL
Wellcome	NULL
Diagnostics	NULL
,	NULL
London	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
concentration	NULL
was	NULL
determined	NULL
to	NULL
be	NULL
0.6	NULL
IU/ml	NULL
,	NULL
at	NULL
which	NULL
>	NULL
90	NULL
%	NULL
of	NULL
cells	NULL
became	NULL
permeable	NULL
to	NULL
trypan	NULL
blue	NULL
within	NULL
1	NULL
min	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
37Â°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
(	NULL
30	NULL
)	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
CD3y	NULL
chain	NULL
induced	NULL
by	NULL
calcium	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
CaCl	NULL
,	NULL
required	NULL
to	NULL
give	NULL
500	NULL
nM	NULL
free	NULL
calcium	NULL
at	NULL
37Â°C	NULL
and	NULL
pH	NULL
7.2	NULL
was	NULL
predicted	NULL
with	NULL
the	NULL
computer	NULL
program	NULL
Chelate	NULL
(	NULL
generous	NULL
gift	NULL
from	NULL
J.	NULL
Down-ward	NULL
)	NULL
with	NULL
appropriate	NULL
dissociation	NULL
constants	NULL
for	NULL
Ca	NULL
*~*	NULL
,	NULL
Mg	NULL
**	NULL
,	NULL
and	NULL
H*	NULL
.	NULL

Subsequent	NULL
cell	NULL
lysis	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-V	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
10	NULL
mM	NULL
benzamidine	NULL
,	NULL
10	NULL
g	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
g	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
trypsin	NULL
inhibitor	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
immunoprecipitation	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
anti-CD3y	NULL
chain	NULL
monoclonal	NULL
antibody	NULL
(	NULL
generous	NULL
gift	NULL
from	NULL
C.	NULL
Terhorst	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Subsequently	NULL
,	NULL
immunoprecipitated	NULL
CD3y	NULL
chains	NULL
were	NULL
separated	NULL
on	NULL
12.5	NULL
%	NULL
acrylamide	NULL
gels	NULL
under	NULL
reducing	NULL
conditions	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
at	NULL
-70Â°C	NULL
.	NULL

Measurement	NULL
of	NULL
ratios	NULL
of	NULL
GTP/GDP	NULL
bound	NULL
to	NULL
p21	NULL
``	NULL
.	NULL

Cells	NULL
(	NULL
50	NULL
x	NULL
10Â°	NULL
per	NULL
treatment	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
phosphate-free	NULL
RPMI	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
dialyzed	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
1	NULL
%	NULL
r-glutamine	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
with	NULL
0.5	NULL
mCi	NULL
of	NULL
Ortho-	NULL
[	NULL
Â°Â°P	NULL
]	NULL
per	NULL
ml	NULL
for	NULL
3	NULL
h.	NULL
Following	NULL
exposure	NULL
to	NULL
200	NULL
ng	NULL
of	NULL
CsA	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
,	NULL
stimulation	NULL
was	NULL
terminated	NULL
by	NULL
lysis	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
-1	NULL
%	NULL
Triton	NULL
X-114-20	NULL
mM	NULL
MgC1	NULL
,	NULL
-150	NULL
mM	NULL
NaCl-10	NULL
ug	NULL
of	NULL
aprotinin	NULL
and	NULL
leupeptin	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
adjusted	NULL
to	NULL
500	NULL
mM	NULL
NaCl	NULL
,	NULL
0.05	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
.	NULL

Immunoprecipitation	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
rat	NULL
anti-Ras	NULL
monoclonal	NULL
antibody	NULL
Y13-259	NULL
(	NULL
Oncogene	NULL
Science	NULL
)	NULL
.	NULL

The	NULL
immuno-precipitates	NULL
were	NULL
washed	NULL
with	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
bound	NULL
nucleotide	NULL
was	NULL
eluted	NULL
with	NULL
2	NULL
mM	NULL
EDTA-2	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
-0.2	NULL
%	NULL
SDS-0.5	NULL
mM	NULL
unlabeled	NULL
GDP	NULL
and	NULL
GTP	NULL
at	NULL
68Â°C	NULL
.	NULL

The	NULL
eluted	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
polycthylencimine-cellulose	NULL
plates	NULL
run	NULL
in	NULL
1.2	NULL
M	NULL
ammonium	NULL
formate-0.8	NULL
M	NULL
HCI	NULL
The	NULL
GTP/GDP	NULL
ratios	NULL
were	NULL
determined	NULL
with	NULL
an	NULL
LKB	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
laser	NULL
densitometer	NULL
and	NULL
software	NULL
.	NULL

Measurement	NULL
of	NULL
MAP	NULL
activation	NULL
.	NULL

Cells	NULL
(	NULL
10	NULL
X	NULL
10Â°	NULL
treatment	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
reagents	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
for	NULL
10	NULL
min	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

Stimulation	NULL
was	NULL
terminated	NULL
by	NULL
lysis	NULL
in	NULL
20	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-2	NULL
mM	NULL
EGTA	NULL
[	NULL
ethylene	NULL
glycol-bis	NULL
(	NULL
B-aminoethyl	NULL
-tetraacetic	NULL
acid	NULL
]	NULL
-5	NULL
mM	NULL
NaF-0.5	NULL
%	NULL
Triton	NULL
X-100-1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
-1	NULL
mM	NULL
DTT-1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluo-ride-0.1	NULL
mM	NULL
benzamidine	NULL
.	NULL

After	NULL
the	NULL
protein	NULL
concentrations	NULL
were	NULL
equalized	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37Â°C	NULL
in	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
and	NULL
100	NULL
M	NULL
ATP	NULL
containing	NULL
2	NULL
wCi	NULL
of	NULL
[	NULL
y-*Â°P	NULL
]	NULL
JATP	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
100	NULL
pM	NULL
okadaic	NULL
acid	NULL
,	NULL
100	NULL
wM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
;	NULL
Sigma	NULL
)	NULL
to	NULL
assay	NULL
MBP	NULL
kinase	NULL
activity	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
then	NULL
spotted	NULL
onto	NULL
P81	NULL
filters	NULL
(	NULL
Whatman	NULL
,	NULL
Fairfield	NULL
,	NULL
N.J.	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
in	NULL
50	NULL
mM	NULL
phosphoric	NULL
acid	NULL
and	NULL
dried	NULL
with	NULL
ethanol	NULL
.	NULL

Radioactively	NULL
labeled	NULL
MBP	NULL
bound	NULL
to	NULL
the	NULL
washed	NULL
filters	NULL
was	NULL
measured	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

EMSA	NULL
.	NULL

Nuclear	NULL
extraction	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
3	NULL
)	NULL
.	NULL

After	NULL
different	NULL
stimula-tions	NULL
,	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10Â°	NULL
)	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
with	NULL
cold	NULL
1	NULL
%	NULL
PBS	NULL
twice	NULL
,	NULL
resuspended	NULL
in	NULL
400	NULL
wl	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Subsequently	NULL
,	NULL
35	NULL
l	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
pellets	NULL
and	NULL
the	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
15-4l	NULL
volumes	NULL
consisting	NULL
of	NULL
100	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
0.5	NULL
M	NULL
potassium	NULL
glutamate	NULL
,	NULL
50	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
,	NULL
50	NULL
%	NULL
glycerol	NULL
,	NULL
3	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
200	NULL
pg	NULL
of	NULL
end-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
,	NULL
and	NULL
10	NULL
g	NULL
of	NULL
nuclear	NULL
extract	NULL
for	NULL
20	NULL
min	NULL
(	NULL
for	NULL
NF-AT	NULL
and	NULL
NF-xB	NULL
binding	NULL
)	NULL
or	NULL
15	NULL
min	NULL
(	NULL
for	NULL
AP-1	NULL
and	NULL
Oct-1	NULL
binding	NULL
)	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
at	NULL
room	NULL
temperature	NULL
on	NULL
5	NULL
%	NULL
acrylamide	NULL
gels	NULL
(	NULL
85	NULL
)	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
EMSA	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
human	NULL
AP-1	NULL
site	NULL
,	NULL
3	NULL
'	NULL
;	NULL
human	NULL
NF-AT	NULL
site	NULL
,	NULL
5-GATCGGAGGAAAAACTGTTTCATACAGAAG	NULL
GCGT-3	NULL
'	NULL
;	NULL
and	NULL
human	NULL
Oct-1	NULL
site	NULL
,	NULL
5'-TGTCGAATGCAAATCACTAGAA-3	NULL
'	NULL
.	NULL

6584	NULL
CHEN	NULL
ET	NULL
AL	NULL
.	NULL

For	NULL
a	NULL
human	NULL
NF-	NULL
Â«	NULL
B	NULL
probe	NULL
,	NULL
the	NULL
upstream	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
c-myc	NULL
gene	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
binding	NULL
site	NULL
5-GGGTITTTCCC-3	NULL
'	NULL
,	NULL
was	NULL
used	NULL
.	NULL

The	NULL
oligonucleotides	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
Â°Â°P	NULL
]	NULL
JATP	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

For	NULL
quan-titation	NULL
,	NULL
autoradiograms	NULL
were	NULL
scanned	NULL
with	NULL
an	NULL
LKB	NULL
laser	NULL
densitometer	NULL
and	NULL
LKB	NULL
software	NULL
.	NULL

IL-2	NULL
immunoassay	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
different	NULL
time	NULL
points	NULL
and	NULL
the	NULL
overlying	NULL
conditioned	NULL
media	NULL
were	NULL
collected	NULL
by	NULL
centrifuga-tion	NULL
.	NULL

An	NULL
ELISA	NULL
for	NULL
IL-2	NULL
protein	NULL
quantitation	NULL
was	NULL
performed	NULL
with	NULL
Quantikine	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
Minn.	NULL
)	NULL
.	NULL

Optical	NULL
densities	NULL
at	NULL
450	NULL
nm	NULL
were	NULL
used	NULL
for	NULL
quantitation	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
activated	NULL
(	NULL
v-Ha-	NULL
)	NULL
ras	NULL
blocks	NULL
the	NULL
induction	NULL
of	NULL
egr-1	NULL
and	NULL
e-fos	NULL
by	NULL
Ca**	NULL
.	NULL

To	NULL
study	NULL
the	NULL
regulatory	NULL
function	NULL
of	NULL
p21	NULL
``	NULL
in	NULL
Ca	NULL
**-mediated	NULL
signal	NULL
transduction	NULL
,	NULL
especially	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
mutated	NULL
at	NULL
codon	NULL
12	NULL
,	NULL
was	NULL
stably	NULL
transfected	NULL
into	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
,	NULL
together	NULL
with	NULL
a	NULL
vector	NULL
conferring	NULL
neomycin	NULL
resistance	NULL
for	NULL
transfection	NULL
selec-tion	NULL
.	NULL

Transfectants	NULL
were	NULL
cloned	NULL
and	NULL
tested	NULL
for	NULL
v-ras	NULL
expression	NULL
(	NULL
the	NULL
resulting	NULL
cell	NULL
lines	NULL
are	NULL
collectively	NULL
designated	NULL
PH1	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
different	NULL
stimuli	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
IE	NULL
genes	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
activated	NULL
v-Ha-ras	NULL
,	NULL
were	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Jurkat	NULL
or	NULL
PH1	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
calcium	NULL
ionophore	NULL
or	NULL
phorbol	NULL
esters	NULL
(	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
[	NULL
PMA	NULL
]	NULL
)	NULL
separately	NULL
,	NULL
and	NULL
RNA	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
quantitate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
egr-1	NULL
and	NULL
c-fos	NULL
genes	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
egr-1	NULL
and	NULL
c-fos	NULL
were	NULL
induced	NULL
by	NULL
both	NULL
calcium	NULL
ionophore	NULL
and	NULL
PMA	NULL
.	NULL

The	NULL
relative	NULL
magnitudes	NULL
of	NULL
the	NULL
inductions	NULL
of	NULL
these	NULL
genes	NULL
were	NULL
higher	NULL
(	NULL
by	NULL
two-	NULL
to	NULL
threefold	NULL
)	NULL
with	NULL
PMA	NULL
than	NULL
with	NULL
calcium	NULL
ionophore	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
activation	NULL
of	NULL
different	NULL
second-messenger	NULL
pathways	NULL
by	NULL
these	NULL
agonists	NULL
and/or	NULL
utilization	NULL
of	NULL
discrete	NULL
gene	NULL
promoter	NULL
or	NULL
enhancer	NULL
re-gions	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
EGTA	NULL
,	NULL
a	NULL
calcium	NULL
chelator	NULL
,	NULL
abolished	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
genes	NULL
after	NULL
treatment	NULL
with	NULL
calcium	NULL
ionophore	NULL
,	NULL
demonstrating	NULL
a	NULL
requirement	NULL
for	NULL
extracellular	NULL
calcium	NULL
.	NULL

In	NULL
(	NULL
v-ras-expressing	NULL
)	NULL
PH1	NULL
cells	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
,	NULL
egr-1	NULL
and	NULL
c-fos	NULL
transcripts	NULL
could	NULL
be	NULL
induced	NULL
by	NULL
PMA	NULL
treatment	NULL
but	NULL
not	NULL
by	NULL
calcium	NULL
ionophore	NULL
treatment	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
blockade	NULL
to	NULL
the	NULL
inductions	NULL
of	NULL
these	NULL
genes	NULL
by	NULL
calcium	NULL
ionophore	NULL
in	NULL
PH1	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cotransfected	NULL
Neo	NULL
vector	NULL
or	NULL
the	NULL
transfection	NULL
and	NULL
selection	NULL
process	NULL
itself	NULL
,	NULL
analysis	NULL
of	NULL
egr-1	NULL
and	NULL
c-fos	NULL
expression	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
Neo	NULL
vector	NULL
alone	NULL
.	NULL

The	NULL
patterns	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
were	NULL
identical	NULL
to	NULL
that	NULL
found	NULL
in	NULL
the	NULL
parental	NULL
Jurkat	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
egr-1	NULL
and	NULL
c-fos	NULL
by	NULL
calcium	NULL
ionophore	NULL
in	NULL
PH1	NULL
cells	NULL
is	NULL
Ras	NULL
spe-cific	NULL
.	NULL

Multiple	NULL
other	NULL
,	NULL
independently	NULL
derived	NULL
lines	NULL
of	NULL
PH1	NULL
cells	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
PH1	NULL
clone	NULL
19	NULL
)	NULL
were	NULL
examined	NULL
in	NULL
similar	NULL
studies	NULL
,	NULL
and	NULL
identical	NULL
results	NULL
were	NULL
obtained	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
and	NULL
b	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
egr-1	NULL
and	NULL
c-fos	NULL
induced	NULL
by	NULL
calcium	NULL
ionophore	NULL
is	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
activated	NULL
p21	NULL
``	NULL
rather	NULL
than	NULL
to	NULL
clonal	NULL
variation	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
the	NULL
inductions	NULL
of	NULL
egr-1	NULL
and	NULL
c-fos	NULL
were	NULL
also	NULL
examined	NULL
in	NULL
Jurkat	NULL
and	NULL
PHI1	NULL
cells	NULL
to	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
activated	NULL
v-Ha-ras	NULL
might	NULL
alter	NULL
the	NULL
time	NULL
or	NULL
duration	NULL
of	NULL
the	NULL
inductions	NULL
of	NULL
the	NULL
genes	NULL
examined	NULL
.	NULL

transcript	NULL
induction	NULL
by	NULL
calcium	NULL
ionophore	NULL
peaked	NULL
between	NULL
1	NULL
to	NULL
2	NULL
h	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
whereas	NULL
c-fos	NULL
transcript	NULL
induction	NULL
peaked	NULL
at	NULL
30	NULL
min	NULL
.	NULL

Examination	NULL
at	NULL
time	NULL
points	NULL
from	NULL
30	NULL
min	NULL
to	NULL
4	NULL
h	NULL
disclosed	NULL
no	NULL
induction	NULL
of	NULL
either	NULL
IE	NULL
transcript	NULL
in	NULL
the	NULL
PH1	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
phenomenon	NULL
of	NULL
the	NULL
blockade	NULL
of	NULL
calcium-dependent	NULL
IE	NULL
gene	NULL
induction	NULL
by	NULL
v-Ha-ras	NULL
observed	NULL
in	NULL
stable	NULL
transfections	NULL
,	NULL
transient	NULL
expression	NULL
of	NULL
a	NULL
c-fos	NULL
promoter-driven	NULL
reporter	NULL
gene	NULL
was	NULL
analyzed	NULL
.	NULL

The	NULL
fos-CAT	NULL
gene	NULL
,	NULL
regulated	NULL
by	NULL
600	NULL
bp	NULL
of	NULL
promoter	NULL
,	NULL
was	NULL
moderately	NULL
induced	NULL
by	NULL
calcium	NULL
ionophore	NULL
in	NULL
Jurkat	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1c	NULL
)	NULL
,	NULL
which	NULL
was	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
observed	NULL
in	NULL
studies	NULL
of	NULL
the	NULL
endogenous	NULL
c-fos	NULL
gene	NULL
in	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

stable	NULL
transfectants	NULL
.	NULL

The	NULL
same	NULL
fos	NULL
promoter-CAT	NULL
gene	NULL
activity	NULL
was	NULL
induced	NULL
by	NULL
either	NULL
PMA	NULL
alone	NULL
or	NULL
PMA	NULL
plus	NULL
calcium	NULL
ionophore	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
activated	NULL
v-Ha-ras	NULL
.	NULL

RNA	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
calcium-independent	NULL
IE	NULL
gene	NULL
,	NULL
the	NULL
c-myc	NULL
gene	NULL
,	NULL
revealed	NULL
that	NULL
c-myc	NULL
transcripts	NULL
could	NULL
be	NULL
induced	NULL
by	NULL
PMA	NULL
treatment	NULL
but	NULL
not	NULL
calcium	NULL
ionophore	NULL
treatment	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
PHI1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
further	NULL
demonstrating	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
activated	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
calcium-activated	NULL
pathway	NULL
and	NULL
not	NULL
a	NULL
general	NULL
inhibitory	NULL
phenomenon	NULL
for	NULL
all	NULL
IE	NULL
gene	NULL
activation	NULL
.	NULL

The	NULL
magnitude	NULL
and	NULL
duration	NULL
of	NULL
Ca	NULL
**	NULL
influx	NULL
stimulated	NULL
by	NULL
calcium	NULL
ionophore	NULL
and	NULL
the	NULL
protein	NULL
expression	NULL
of	NULL
calcineurin	NULL
in	NULL
PH1	NULL
cells	NULL
were	NULL
examined	NULL
,	NULL
in	NULL
comparison	NULL
with	NULL
those	NULL
features	NULL
in	NULL
Jurkat	NULL
and	NULL
Neo	NULL
(	NULL
control	NULL
)	NULL
cells	NULL
,	NULL
to	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
blockade	NULL
to	NULL
calcium-activated	NULL
IE	NULL
gene	NULL
induction	NULL
by	NULL
v-Ha-ras	NULL
represents	NULL
a	NULL
secondary	NULL
adaptive	NULL
mechanism	NULL
to	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
in	NULL
which	NULL
calcium	NULL
mobilization	NULL
in	NULL
response	NULL
to	NULL
ionophore	NULL
was	NULL
impaired	NULL
or	NULL
calcineurin	NULL
levels	NULL
were	NULL
altered	NULL
.	NULL

The	NULL
magnitude	NULL
and	NULL
duration	NULL
of	NULL
calcium	NULL
flux	NULL
induced	NULL
by	NULL
ionophore	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
indicator	NULL
INDO-1	NULL
,	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
in	NULL
multiple	NULL
PH1	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
Neo	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
were	NULL
cellular	NULL
calcineurin	NULL
levels	NULL
,	NULL
suggesting	NULL
that	NULL
transfected	NULL
v-Ha-ras	NULL
does	NULL
not	NULL
alter	NULL
these	NULL
aspects	NULL
of	NULL
Ca	NULL
**	NULL
signaling	NULL
.	NULL

egr-7	NULL
transcript	NULL
induction	NULL
by	NULL
calcium	NULL
ionophore	NULL
or	NULL
by	NULL
PMA	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
unaffected	NULL
after	NULL
incubating	NULL
Jurkat	NULL
cells	NULL
in	NULL
medium	NULL
conditioned	NULL
with	NULL
PH1	NULL
cell	NULL
cultures	NULL
for	NULL
48	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
excluding	NULL
the	NULL
possibility	NULL
of	NULL
an	NULL
autocrine	NULL
inhibitory	NULL
effect	NULL
on	NULL
calcium-dependent	NULL
IE	NULL
gene	NULL
in	NULL
p21	NULL
``	NULL
``	NULL
.	NULL

The	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
blockade	NULL
to	NULL
induction	NULL
of	NULL
egr-7	NULL
and	NULL
c-fos	NULL
by	NULL
calcium	NULL
is	NULL
PKC	NULL
independent	NULL
.	NULL

T	NULL
lymphocytes	NULL
express	NULL
two	NULL
major	NULL
PKC	NULL
isoforms	NULL
,	NULL
a	NULL
and	NULL
B	NULL
(	NULL
15	NULL
,	NULL
42	NULL
,	NULL
63	NULL
,	NULL
64	NULL
)	NULL
.	NULL

These	NULL
different	NULL
isoforms	NULL
of	NULL
PKC	NULL
can	NULL
be	NULL
distinguished	NULL
by	NULL
their	NULL
differential	NULL
sensitivities	NULL
to	NULL
calcium	NULL
,	NULL
the	NULL
Â«	NULL
isoform	NULL
of	NULL
PKC	NULL
being	NULL
several	NULL
log	NULL
units	NULL
more	NULL
calcium	NULL
dependent	NULL
than	NULL
B	NULL
isoform	NULL
(	NULL
2	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
PKC	NULL
a	NULL
isotype	NULL
but	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
PKC	NULL
B	NULL
isotype	NULL
(	NULL
52	NULL
)	NULL
,	NULL
in	NULL
comparison	NULL
with	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphocytes	NULL
which	NULL
contain	NULL
high	NULL
levels	NULL
of	NULL
PKC	NULL
B	NULL
but	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
a	NULL
isotype	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
activated	NULL
p21	NULL
``	NULL
might	NULL
cause	NULL
a	NULL
change	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
PKC	NULL
isoforms	NULL
,	NULL
and	NULL
perhaps	NULL
a	NULL
change	NULL
in	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
Ca**	NULL
,	NULL
thereby	NULL
altering	NULL
expression	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
in	NULL
response	NULL
to	NULL
calcium	NULL
ionophore	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
PKC	NULL
a	NULL
and	NULL
B	NULL
isoforms	NULL
were	NULL
determined	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
PKC	NULL
B	NULL
(	NULL
80-kDa	NULL
)	NULL
and	NULL
Â«	NULL
(	NULL
82-kDa	NULL
)	NULL
isoforms	NULL
were	NULL
observed	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
the	NULL
CD37	NULL
chain	NULL
is	NULL
one	NULL
of	NULL
the	NULL
substrates	NULL
for	NULL
PKC	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
9	NULL
,	NULL
25	NULL
,	NULL
70	NULL
,	NULL
84	NULL
)	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
CD3y	NULL
chain	NULL
was	NULL
assayed	NULL
under	NULL
conditions	NULL
of	NULL
500	NULL
nM	NULL
free	NULL
calcium	NULL
or	NULL
100	NULL
nM	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

Free	NULL
calcium	NULL
(	NULL
500	NULL
nM	NULL
)	NULL
induced	NULL
phosphorylation	NULL
of	NULL
the	NULL
CD37	NULL
chain	NULL
,	NULL
which	NULL
was	NULL
further	NULL
enhanced	NULL
twofold	NULL
by	NULL
PMA	NULL
treatment	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
isoforms	NULL
of	NULL
PKC	NULL
is	NULL
unchanged	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
activated	NULL
p21	NULL
``	NULL
``	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
inductions	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
by	NULL
calcium	NULL
ionophore	NULL
treatment	NULL
in	NULL
Jurkat	NULL
and	NULL
PH1	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
the	NULL
altered	NULL
regulatory	NULL
influence	NULL
of	NULL
intracellular	NULL
calcium	NULL
levels	NULL
on	NULL
PKC	NULL
activity	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
down-regulation	NULL
of	NULL
PKC	NULL
activity	NULL
by	NULL
prolonged	NULL
treatment	NULL
with	NULL
high	NULL
concentrations	NULL
of	NULL
PMA	NULL
on	NULL
IE	NULL
gene	NULL
induction	NULL
was	NULL
examined	NULL
.	NULL

Down-regulation	NULL
of	NULL
PKC	NULL
by	NULL
high	NULL
doses	NULL
of	NULL
PMA	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
recruitment	NULL
of	NULL
cytoplasmic	NULL
PKC	NULL
enzyme	NULL
to	NULL
the	NULL
cellular	NULL
mem-brane	NULL
,	NULL
where	NULL
it	NULL
is	NULL
rapidly	NULL
degraded	NULL
by	NULL
a	NULL
protease	NULL
(	NULL
60	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
any	NULL
residual	NULL
activity	NULL
of	NULL
PKC	NULL
after	NULL
down-regulation	NULL
,	NULL
phosphorylation	NULL
of	NULL
the	NULL
CD3y	NULL
chain	NULL
,	NULL
a	NULL
PKC	NULL
substrate	NULL
,	NULL
was	NULL
assayed	NULL
in	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
28	NULL
)	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2Â¢c	NULL
)	NULL
.	NULL

After	NULL
prolonged	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
a	NULL
Jurkat	NULL
Neo	NULL
285	NULL
-	NULL
>	NULL
Â«	NULL
a	NULL
Gth	NULL
~	NULL
.	NULL

<	NULL
_egr_1	NULL
188-	NULL
Â»	NULL
EGTA	NULL
-	NULL
o=	NULL
-	NULL
+	NULL
PMA	NULL
=	NULL
=	NULL
0	NULL
#	NULL
-	NULL
-o	NULL
-	NULL
+	NULL
lona	NULL
-	NULL
+	NULL
-	NULL
+	NULL
600	NULL
+	NULL
o-PH1	NULL
(	NULL
7	NULL
)	NULL
PH1	NULL
(	NULL
19	NULL
)	NULL
288	NULL
-t	NULL
Â»	NULL
as	NULL
.	NULL

<	NULL
_egr_1	NULL
188	NULL
-	NULL
Â»	NULL
EGTA	NULL
-	NULL
-	NULL
-	NULL
+	NULL
PMA	NULL
=	NULL
-	NULL
-	NULL
0	NULL
#	NULL
o-	NULL
-o	NULL
}	NULL
+	NULL
lono	NULL
=	NULL
+	NULL
-	NULL
+	NULL
-o	NULL
$	NULL
ob	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
Neo	NULL
288	NULL
--	NULL
(	NULL
se	NULL
m	NULL
-	NULL
@	NULL
dase	NULL
-	NULL
<	NULL
-fos	NULL
EGTA	NULL
-	NULL
-	NULL
-	NULL
+	NULL
so	NULL
>	NULL
00	NULL
}	NULL
#	NULL
PMA	NULL
=	NULL
o=	NULL
0	NULL
#	NULL
>	NULL
00	NULL
=	NULL
o=	NULL
o	NULL
#	NULL
>	NULL
0	NULL
o-	NULL
-	NULL
o	NULL
o+	NULL
#	NULL
+	NULL
lono	NULL
_-	NULL
+	NULL
=	NULL
+	NULL
=	NULL
+o	NULL
-	NULL
+	NULL
-	NULL
+	NULL
C	NULL
20	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
eggs	NULL
e	NULL
[	NULL
]	NULL
control	NULL
\o	NULL
-	NULL
-	NULL
o	NULL
o	NULL
-	NULL
CZ	NULL
]	NULL
lono	NULL
8004	NULL
0+	NULL
--	NULL
+	NULL
_-	NULL
fono	NULL
Â£00600	NULL
#	NULL
00	NULL
}	NULL
0+	NULL
+	NULL
PMA	NULL
EPMA	NULL
RBB	NULL
15	NULL
>	NULL
Z	NULL
>	NULL
fu	NULL
)	NULL
O	NULL
<	NULL
10	NULL
7	NULL
Fâ	NULL
<	NULL
C	NULL
O	NULL
50	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
Cell	NULL
Line	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Induction	NULL
of	NULL
egr-7	NULL
and	NULL
c-fos	NULL
gene	NULL
expression	NULL
by	NULL
calcium	NULL
ionophore	NULL
or	NULL
PMA	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Total	NULL
cellular	NULL
RNAs	NULL
were	NULL
extracted	NULL
from	NULL
Jurkat	NULL
,	NULL
PH1	NULL
clones	NULL
7	NULL
and	NULL
19	NULL
,	NULL
and	NULL
neo	NULL
transfectants	NULL
after	NULL
incubation	NULL
in	NULL
2	NULL
M	NULL
calcium	NULL
ionophore	NULL
(	NULL
Iono	NULL
)	NULL
or	NULL
100	NULL
nM	NULL
PMA	NULL
for	NULL
1	NULL
h	NULL
or	NULL
exposure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
200	NULL
nM	NULL
EGTA	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
calcium	NULL
ionophore	NULL
treatment	NULL
.	NULL

After	NULL
fractionation	NULL
of	NULL
15-pg	NULL
RNA	NULL
samples	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
and	NULL
transfer	NULL
to	NULL
BioBlot-supported	NULL
nitrocellulose	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
egr-7	NULL
transcript	NULL
expression	NULL
were	NULL
determined	NULL
by	NULL
hybridization	NULL
to	NULL
random-primed	NULL
cDNA	NULL
probes	NULL
.	NULL

B-acfin	NULL
transcripts	NULL
were	NULL
probed	NULL
for	NULL
as	NULL
controls	NULL
for	NULL
equal	NULL
loadings	NULL
and	NULL
transfers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
panel	NULL
shows	NULL
an	NULL
autoradiogram	NULL
.	NULL

The	NULL
migration	NULL
positions	NULL
of	NULL
the	NULL
egr-7	NULL
and	NULL
c-fos	NULL
transcripts	NULL
are	NULL
marked	NULL
,	NULL
as	NULL
are	NULL
the	NULL
positions	NULL
of	NULL
188	NULL
and	NULL
288	NULL
rRNA	NULL
species	NULL
.	NULL

(	NULL
b	NULL
)	NULL
After	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
indicated	NULL
for	NULL
30	NULL
min	NULL
,	NULL
cellular	NULL
RNAs	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
and	NULL
subsequently	NULL
probed	NULL
for	NULL
c-fos	NULL
expression	NULL
.	NULL

(	NULL
c	NULL
)	NULL
A	NULL
c-fos	NULL
promoter-CAT	NULL
chimeric	NULL
gene	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
either	NULL
Jurkat	NULL
or	NULL
PHI1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
.	NULL

After	NULL
being	NULL
stimulated	NULL
as	NULL
indicated	NULL
for	NULL
4	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
assay	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

control	NULL
,	NULL
untreated	NULL
control	NULL
;	NULL
Iono	NULL
,	NULL
2	NULL
M	NULL
calcium	NULL
ionophore	NULL
;	NULL
PMA	NULL
,	NULL
100	NULL
nM	NULL
PMA	NULL
;	NULL
Iono	NULL
+	NULL
PMA	NULL
,	NULL
100	NULL
nM	NULL
PMA	NULL
plus	NULL
2	NULL
wM	NULL
calcium	NULL
ionophore	NULL
.	NULL

Standard	NULL
error	NULL
bars	NULL
are	NULL
NEGATIVE	NULL
REGULATION	NULL
OF	NULL
IE	NULL
GENE	NULL
EXPRESSION	NULL
BY	NULL
Ras	NULL
6585	NULL
treatment	NULL
(	NULL
24	NULL
h	NULL
)	NULL
with	NULL
500	NULL
nM	NULL
PMA	NULL
,	NULL
the	NULL
CD37	NULL
chain	NULL
was	NULL
no	NULL
longer	NULL
phosphorylated	NULL
by	NULL
restimulation	NULL
with	NULL
100	NULL
nM	NULL
PMA	NULL
in	NULL
either	NULL
cell	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

2Â¢	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
;	NULL
compare	NULL
these	NULL
results	NULL
with	NULL
the	NULL
results	NULL
of	NULL
stimulation	NULL
with	NULL
100	NULL
nM	NULL
PMA	NULL
in	NULL
control	NULL
cells	NULL
[	NULL
Fig	NULL
.	NULL

2Â¢	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
]	NULL
)	NULL
,	NULL
demonstrating	NULL
full	NULL
suppression	NULL
of	NULL
PKC	NULL
activity	NULL
.	NULL

Following	NULL
down-regulation	NULL
of	NULL
PKC	NULL
activity	NULL
by	NULL
24	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
500	NULL
nM	NULL
PMA	NULL
,	NULL
retreatment	NULL
with	NULL
100	NULL
nM	NULL
PMA	NULL
did	NULL
not	NULL
efficiently	NULL
induce	NULL
the	NULL
gene	NULL
in	NULL
either	NULL
cell	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

2d	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
further	NULL
demonstrating	NULL
the	NULL
abrogation	NULL
of	NULL
PKC	NULL
activity	NULL
by	NULL
this	NULL
treatment	NULL
.	NULL

After	NULL
abolition	NULL
of	NULL
PKC	NULL
activity	NULL
by	NULL
a	NULL
high-dose-PMA	NULL
treatment	NULL
,	NULL
egr-	NULL
remained	NULL
inducible	NULL
in	NULL
Jurkat	NULL
cells	NULL
by	NULL
calcium	NULL
ionophore	NULL
treatment	NULL
but	NULL
not	NULL
in	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
as	NULL
expected	NULL
(	NULL
Fig	NULL
.	NULL

2d	NULL
)	NULL
,	NULL
thus	NULL
ruling	NULL
out	NULL
a	NULL
role	NULL
for	NULL
PKC	NULL
in	NULL
the	NULL
mediation	NULL
of	NULL
the	NULL
calcium	NULL
signal	NULL
.	NULL

p21'*-mediated	NULL
inhibition	NULL
of	NULL
IE	NULL
gene	NULL
expression	NULL
is	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

The	NULL
immunosuppressant	NULL
CsA	NULL
can	NULL
bind	NULL
to	NULL
immunophi-lin	NULL
and	NULL
further	NULL
inhibit	NULL
calcineurin	NULL
,	NULL
a	NULL
calcium-	NULL
or	NULL
calmodulin-regulated	NULL
serine	NULL
or	NULL
threonine	NULL
phosphatase	NULL
,	NULL
thus	NULL
blocking	NULL
T-cell	NULL
function	NULL
by	NULL
preventing	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
gene	NULL
that	NULL
encodes	NULL
the	NULL
T-cell	NULL
growth	NULL
factor	NULL
IL-2	NULL
.	NULL

Calcineurin	NULL
is	NULL
a	NULL
major	NULL
component	NULL
of	NULL
the	NULL
calcium	NULL
signaling	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
mediating	NULL
T-cell	NULL
activation	NULL
via	NULL
regulation	NULL
of	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NF-AT	NULL
(	NULL
NF-ATp	NULL
)	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-AT	NULL
(	NULL
14	NULL
,	NULL
22	NULL
,	NULL
37	NULL
,	NULL
54	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Because	NULL
p21	NULL
``	NULL
``	NULL
negatively	NULL
regulated	NULL
the	NULL
calcium-dependent	NULL
induction	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
egr-1	NULL
and	NULL
c-fos	NULL
as	NULL
demonstrated	NULL
above	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
after	NULL
stimulation	NULL
with	NULL
either	NULL
calcium	NULL
ionophore	NULL
or	NULL
PMA	NULL
was	NULL
examined	NULL
after	NULL
pretreatment	NULL
with	NULL
CsA	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
egr-1	NULL
and	NULL
c-fos	NULL
genes	NULL
in	NULL
PH1	NULL
cells	NULL
by	NULL
calcium	NULL
ionophore	NULL
was	NULL
restored	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
p21	NULL
``	NULL
may	NULL
exert	NULL
its	NULL
negative	NULL
regulatory	NULL
function	NULL
via	NULL
calcineurin	NULL
and	NULL
that	NULL
such	NULL
regulation	NULL
is	NULL
calcium	NULL
dependent	NULL
.	NULL

In	NULL
parental	NULL
(	NULL
or	NULL
control-transfected	NULL
)	NULL
Jurkat	NULL
cells	NULL
,	NULL
these	NULL
genes	NULL
were	NULL
induced	NULL
normally	NULL
by	NULL
ionophore	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

PMA	NULL
treatment	NULL
also	NULL
induced	NULL
egr-1	NULL
and	NULL
c-fos	NULL
gene	NULL
expression	NULL
normally	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

In	NULL
the	NULL
control	NULL
lanes	NULL
for	NULL
this	NULL
blot	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1a	NULL
and	NULL
b	NULL
,	NULL
CsA	NULL
alone	NULL
did	NULL
not	NULL
cause	NULL
the	NULL
induction	NULL
of	NULL
egr-7	NULL
or	NULL
c-fos	NULL
.	NULL

In	NULL
transient-expression	NULL
assays	NULL
using	NULL
the	NULL
600-bp	NULL
c-fos	NULL
promoter-CAT	NULL
reporter	NULL
gene	NULL
chimera	NULL
,	NULL
the	NULL
fos-CAT	NULL
gene	NULL
was	NULL
rendered	NULL
inducible	NULL
by	NULL
calcium	NULL
ionophore	NULL
in	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
;	NULL
compare	NULL
with	NULL
Fig	NULL
.	NULL

1Â¢c	NULL
)	NULL
to	NULL
levels	NULL
observed	NULL
in	NULL
control	NULL
Jurkat	NULL
cells	NULL
.	NULL

Oncogenic	NULL
,	NULL
activated	NULL
Ras	NULL
,	NULL
through	NULL
a	NULL
decrease	NULL
in	NULL
its	NULL
level	NULL
of	NULL
intrinsic	NULL
guanosine	NULL
triphosphatase	NULL
activity	NULL
or	NULL
an	NULL
elevation	NULL
of	NULL
its	NULL
exchange	NULL
rate	NULL
of	NULL
GDP	NULL
to	NULL
GTP	NULL
,	NULL
or	NULL
by	NULL
prolonging	NULL
its	NULL
association	NULL
with	NULL
GTP	NULL
,	NULL
thereby	NULL
maintaining	NULL
its	NULL
active	NULL
form	NULL
,	NULL
can	NULL
stimulate	NULL
cellular	NULL
growth	NULL
and	NULL
cause	NULL
transformation	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
MAP	NULL
kinases	NULL
,	NULL
which	NULL
are	NULL
stimulated	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
p21	NULL
``	NULL
activation	NULL
in	NULL
many	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
,	NULL
were	NULL
examined	NULL
in	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3Â¢	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
activity	NULL
of	NULL
MAP	NULL
kinases	NULL
in	NULL
untreated	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
were	NULL
consistently	NULL
higher	NULL
than	NULL
in	NULL
the	NULL
untreated	NULL
control	NULL
Jurkat	NULL
cells	NULL
.	NULL

PMA	NULL
plus	NULL
calcium	NULL
ionophore	NULL
or	NULL
PMA	NULL
alone	NULL
induced	NULL
elevated	NULL
levels	NULL
of	NULL
MAP	NULL
kinase	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
indicating	NULL
that	NULL
constitutively	NULL
activated	NULL
v-Ha-ras	NULL
did	NULL
not	NULL
significantly	NULL
alter	NULL
the	NULL
responsiveness	NULL
of	NULL
this	NULL
downstream	NULL
effector	NULL
.	NULL

Treatment	NULL
with	NULL
CsA	NULL
similarly	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
constitutive	NULL
or	NULL
induced	NULL
MAP	NULL
kinase	NULL
activity	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
to	NULL
assess	NULL
whether	NULL
the	NULL
blockade	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
activity	NULL
on	NULL
the	NULL
calcium-activated	NULL
gene	NULL
induction	NULL
shown	NULL
.	NULL

Cotransfections	NULL
with	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
B-galactosidase	NULL
vector	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
verified	NULL
equivalent	NULL
efficiencies	NULL
of	NULL
transfection	NULL
.	NULL

The	NULL
figure	NULL
inset	NULL
is	NULL
an	NULL
autoradiogram	NULL
of	NULL
the	NULL
same	NULL
type	NULL
of	NULL
experiment	NULL
,	NULL
but	NULL
one	NULL
in	NULL
which	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
chromatography	NULL
rather	NULL
than	NULL
by	NULL
organic	NULL
extraction	NULL
.	NULL

6586	NULL
CHEN	NULL
ET	NULL
AL	NULL
.	NULL

a	NULL
A	NULL
O	NULL
n	NULL
a\	NULL
&	NULL
.C	NULL
,	NULL
>	NULL
13	NULL
Â»	NULL
_	NULL
Â¢	NULL
_	NULL
g8	NULL
<	NULL
4-PKC	NULL
o.	NULL
PKC	NULL
B	NULL
-t	NULL
Â»	NULL
b	NULL
v	NULL
so	NULL
s	NULL
``	NULL
s	NULL
``	NULL
sÂ¢	NULL
aÂ¢	NULL
5	NULL
w	NULL
&	NULL
Â«	NULL
-	NULL
Â»	NULL
_-	NULL
Â»	NULL
606Â°	NULL
6	NULL
&	NULL
0	NULL
,	NULL
C	NULL
g	NULL
,	NULL
C	NULL
&	NULL
``	NULL
,0	NULL
Â¥	NULL
C	NULL
F	NULL
gC	NULL
yo	NULL
gÂ¢	NULL
une	NULL
.	NULL

cae	NULL
<	NULL
-CD3	NULL
y	NULL
C	NULL
$	NULL
_	NULL
4qF	NULL
&	NULL
P	NULL
Cal	NULL
F	NULL
&	NULL
C	NULL
,	NULL
C	NULL
8	NULL
&	NULL
C	NULL
6	NULL
sÂ¢	NULL
$	NULL
Â®	NULL
$	NULL
_	NULL
$	NULL
&	NULL
,	NULL
C	NULL
&	NULL
,	NULL
C	NULL
a	NULL
A	NULL
a	NULL
A	NULL
F	NULL
3	NULL
w	NULL
g	NULL
CD3	NULL
y	NULL
-t	NULL
Â»	NULL
sein	NULL
d	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
285	NULL
-t	NULL
mp	NULL
|	NULL
<	NULL
-	NULL
egr-1	NULL
185-	NULL
Â»	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
-	NULL
PMA	NULL
500	NULL
nM	NULL
24h	NULL
=	NULL
+	NULL
=	NULL
=	NULL
+	NULL
--	NULL
lono	NULL
l	NULL
-o	NULL
-	NULL
0	NULL
+	NULL
PMA	NULL
FIG	NULL
.	NULL

2.	NULL
egr-1	NULL
and	NULL
c-fos	NULL
expression	NULL
induced	NULL
by	NULL
calcium	NULL
ionophore	NULL
is	NULL
PKC	NULL
independent	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Immunoblotting	NULL
of	NULL
PKC	NULL
Â«	NULL
and	NULL
B	NULL
isoforms	NULL
.	NULL

Lysates	NULL
from	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
were	NULL
immunoblotted	NULL
with	NULL
either	NULL
an	NULL
anti-PKC	NULL
B-specific	NULL
monoclonal	NULL
antibody	NULL
or	NULL
an	NULL
anti-PKC	NULL
Â«	NULL
-specific	NULL
monoclonal	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
migration	NULL
positions	NULL
of	NULL
these	NULL
isoforms	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Calcium	NULL
and	NULL
PMA	NULL
stimulation	NULL
of	NULL
CD3y	NULL
chain	NULL
phosphorylation	NULL
in	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
.	NULL

Permeabilized	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
500	NULL
nM	NULL
free	NULL
calcium	NULL
or	NULL
100	NULL
nM	NULL
PMA	NULL
together	NULL
with	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
.	NULL

After	NULL
being	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-CD3y	NULL
chain	NULL
antibody	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Contl	NULL
,	NULL
control	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Jurkat	NULL
and	NULL
PH1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
500	NULL
nM	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
permeabilized	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
nM	NULL
PMA	NULL
and	NULL
[	NULL
y-*Â°P	NULL
]	NULL
ATP	NULL
.	NULL

After	NULL
immunoprecipitation	NULL
with	NULL
an	NULL
anti-CD3y	NULL
chain	NULL
antibody	NULL
,	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

(	NULL
d	NULL
)	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
500	NULL
nM	NULL
of	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
and	NULL
stimulated	NULL
with	NULL
2	NULL
wM	NULL
calcium	NULL
ionophore	NULL
(	NULL
Iono	NULL
)	NULL
or	NULL
100	NULL
nM	NULL
PMA	NULL
for	NULL
1	NULL
h.	NULL
Fifteen	NULL
nanograms	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
fractionated	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
BioBlot-supported	NULL
nitrocellu-lose	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
egr-7	NULL
expression	NULL
were	NULL
determined	NULL
by	NULL
hybridization	NULL
with	NULL
random-primed	NULL
cDNA	NULL
probes	NULL
.	NULL

B-ectin	NULL
transcripts	NULL
were	NULL
probed	NULL
for	NULL
as	NULL
controls	NULL
for	NULL
equal	NULL
loadings	NULL
and	NULL
transfers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

pathway	NULL
by	NULL
CsA	NULL
might	NULL
be	NULL
due	NULL
to	NULL
direct	NULL
interference	NULL
by	NULL
CsA	NULL
with	NULL
a	NULL
GTP-dependent	NULL
p21	NULL
``	NULL
``	NULL
effector	NULL
activity	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
the	NULL
ratio	NULL
of	NULL
guanosine	NULL
nucleotides	NULL
binding	NULL
to	NULL
p21	NULL
``	NULL
``	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
relative	NULL
ratios	NULL
of	NULL
the	NULL
GTP-bound	NULL
form	NULL
of	NULL
p21	NULL
``	NULL
in	NULL
untreated	NULL
PHI1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
were	NULL
increased	NULL
(	NULL
by	NULL
an	NULL
average	NULL
of	NULL
1.8-fold	NULL
)	NULL
in	NULL
comparison	NULL
with	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
,	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

as	NULL
expected	NULL
,	NULL
and	NULL
CsA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
activation	NULL
in	NULL
either	NULL
cell	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

3d	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
c-fos	NULL
by	NULL
calcium	NULL
in	NULL
a	NULL
pheochromocytoma	NULL
cell	NULL
line	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
a	NULL
calmodulin	NULL
kinase	NULL
II-dependent	NULL
pathway	NULL
and	NULL
the	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
-responsive	NULL
binding	NULL
protein	NULL
CREB	NULL
(	NULL
57	NULL
,	NULL
73	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
negative	NULL
regulatory	NULL
function	NULL
of	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
on	NULL
calcium-dependent	NULL
IE	NULL
gene	NULL
induction	NULL
,	NULL
specific	NULL
regulators	NULL
of	NULL
these	NULL
and	NULL
other	NULL
potential	NULL
second	NULL
messengers	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
involvement	NULL
of	NULL
molecules	NULL
related	NULL
to	NULL
different	NULL
signaling	NULL
pathways	NULL
.	NULL

Sirolimus	NULL
,	NULL
which	NULL
blocks	NULL
signaling	NULL
by	NULL
the	NULL
70-kDa	NULL
S6	NULL
protein	NULL
kinases	NULL
(	NULL
pp70Â°Â°*	NULL
)	NULL
(	NULL
13	NULL
)	NULL
,	NULL
forskolin	NULL
(	NULL
a	NULL
stimulator	NULL
of	NULL
the	NULL
cAMP	NULL
-regulated	NULL
protein	NULL
kinase	NULL
PKA	NULL
)	NULL
,	NULL
or	NULL
a	NULL
calmodulin	NULL
kinase	NULL
inhibitor	NULL
was	NULL
added	NULL
to	NULL
cell	NULL
cultures	NULL
before	NULL
stimulation	NULL
with	NULL
PMA	NULL
or	NULL
calcium	NULL
ionophore	NULL
.	NULL

None	NULL
of	NULL
these	NULL
inhibitors	NULL
had	NULL
any	NULL
effect	NULL
on	NULL
egr-1	NULL
induction	NULL
by	NULL
calcium	NULL
ionophore	NULL
or	NULL
by	NULL
PMA	NULL
or	NULL
on	NULL
its	NULL
inhibition	NULL
by	NULL
activated	NULL
p21	NULL
``	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Activated	NULL
p21	NULL
``	NULL
inhibits	NULL
calcium-dependent	NULL
c-gjun	NULL
induction	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
is	NULL
not	NULL
CsA	NULL
sensitive	NULL
.	NULL

Some	NULL
jur	NULL
gene	NULL
family	NULL
members	NULL
are	NULL
reported	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
calcium	NULL
signals	NULL
(	NULL
18	NULL
,	NULL
33	NULL
,	NULL
38	NULL
,	NULL
75	NULL
)	NULL
.	NULL

As	NULL
Jun	NULL
proteins	NULL
are	NULL
important	NULL
components	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
complex	NULL
and	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
calcium-dependent	NULL
regulation	NULL
of	NULL
the	NULL
activities	NULL
of	NULL
other	NULL
transactivators	NULL
(	NULL
such	NULL
as	NULL
OAP-1	NULL
)	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
constitutively	NULL
activated	NULL
p21	NULL
``	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
c-jun	NULL
by	NULL
calcium	NULL
ionophore	NULL
was	NULL
assessed	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Calcium	NULL
ionophore	NULL
or	NULL
PMA	NULL
treatment	NULL
induced	NULL
c-jun	NULL
transcript	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
magnitude	NULL
of	NULL
c-jun	NULL
induction	NULL
by	NULL
PMA	NULL
was	NULL
consistently	NULL
slightly	NULL
greater	NULL
(	NULL
by	NULL
1.8-	NULL
to	NULL
2.3-fold	NULL
)	NULL
than	NULL
by	NULL
calcium	NULL
ionophore	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
p21	NULL
``	NULL
,	NULL
this	NULL
induction	NULL
by	NULL
ionophore	NULL
,	NULL
but	NULL
not	NULL
by	NULL
PMA	NULL
,	NULL
was	NULL
blocked	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
effects	NULL
on	NULL
egr-1	NULL
and	NULL
c-fos	NULL
,	NULL
however	NULL
,	NULL
pretreatment	NULL
with	NULL
CsA	NULL
did	NULL
not	NULL
restore	NULL
induction	NULL
of	NULL
c-jun	NULL
by	NULL
calcium	NULL
ionophore	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
c-jun	NULL
transcript	NULL
expression	NULL
by	NULL
p21	NULL
``	NULL
``	NULL
thus	NULL
differs	NULL
from	NULL
those	NULL
of	NULL
egr-1	NULL
and	NULL
c-fos	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-1	NULL
is	NULL
a	NULL
potential	NULL
target	NULL
of	NULL
negative	NULL
regulation	NULL
by	NULL
activated	NULL
p21	NULL
``	NULL
.	NULL

The	NULL
transcriptional	NULL
factor	NULL
complex	NULL
AP-1	NULL
consists	NULL
of	NULL
either	NULL
Fos-Jun	NULL
family	NULL
heterodimers	NULL
or	NULL
Jun-Jun	NULL
family	NULL
homodimers	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
both	NULL
preexisting	NULL
and	NULL
newly	NULL
synthesized	NULL
AP-1	NULL
are	NULL
subject	NULL
to	NULL
both	NULL
posttranslational	NULL
modulation	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
protein	NULL
activities	NULL
and	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
(	NULL
8	NULL
,	NULL
16	NULL
,	NULL
40	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
at	NULL
early	NULL
time	NULL
points	NULL
likely	NULL
involves	NULL
posttranslational	NULL
modification	NULL
of	NULL
preexisting	NULL
Fos	NULL
and/or	NULL
Jun	NULL
components	NULL
,	NULL
as	NULL
new	NULL
protein	NULL
synthesis	NULL
is	NULL
not	NULL
required	NULL
.	NULL

Since	NULL
activated	NULL
p21	NULL
``	NULL
negatively	NULL
regulated	NULL
the	NULL
induction	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcripts	NULL
in	NULL
response	NULL
to	NULL
calcium	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
this	NULL
inhibitory	NULL
effect	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
influenced	NULL
the	NULL
duration	NULL
of	NULL
induced	NULL
AP-1	NULL
activity	NULL
,	NULL
which	NULL
de-pends	NULL
,	NULL
at	NULL
later	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
,	NULL
on	NULL
the	NULL
continued	NULL
production	NULL
of	NULL
new	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
.	NULL

To	NULL
test	NULL
this	NULL
predic-tion	NULL
,	NULL
EMSA	NULL
of	NULL
AP-1	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
IL-2	NULL
activation	NULL
,	NULL
including	NULL
NF-AT	NULL
,	NULL
NF-	NULL
Â«	NULL
B	NULL
,	NULL
and	NULL
Oct-1	NULL
,	NULL
were	NULL
performed	NULL
at	NULL
different	NULL
times	NULL
after	NULL
stimulation	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
calcium	NULL
ionophore	NULL
,	NULL
which	NULL
mimics	NULL
stimulation	NULL
through	NULL
the	NULL
TeR	NULL
,	NULL
for	NULL
4	NULL
,	NULL
6	NULL
,	NULL
or	NULL
8	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Oct-1	NULL
was	NULL
constitutively	NULL
expressed	NULL
and	NULL
its	NULL
levels	NULL
were	NULL
unchanged	NULL
in	NULL
nuclear	NULL
extracts	NULL
at	NULL
all	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5d	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
DNA-binding	NULL
activities	NULL
of	NULL
NF-AT	NULL
,	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
to	NULL
c	NULL
)	NULL
were	NULL
strongly	NULL
induced	NULL
by	NULL
stimulation	NULL
,	NULL
in	NULL
comparison	NULL
with	NULL
those	NULL
of	NULL
the	NULL
unstimulated	NULL
controls	NULL
.	NULL

The	NULL
relative	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-AT	NULL
,	NULL
NF-	NULL
Â«	NULL
B	NULL
,	NULL
or	NULL
Oct-1	NULL
did	NULL
not	NULL
show	NULL
subsequent	NULL
changes	NULL
,	NULL
however	NULL
,	NULL
over	NULL
the	NULL
time	NULL
course	NULL
examined	NULL
.	NULL

The	NULL
level	NULL
of	NULL
DNA-binding	NULL
activity	NULL
of	NULL
AP-1	NULL
in	NULL
the	NULL
control	NULL
Jurkat	NULL
cells	NULL
continued	NULL
to	NULL
increase	NULL
over	NULL
time	NULL
(	NULL
by	NULL
1.8-fold	NULL
over	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
NEGATIVE	NULL
REGULATION	NULL
OF	NULL
IE	NULL
GENE	NULL
EXPRESSION	NULL
BY	NULL
Ras	NULL
6587	NULL
a	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
28S-A	NULL
Â»	NULL
>	NULL
i	NULL
Â«	NULL
Â»	NULL
Â®	NULL
__	NULL
Â»	NULL
us	NULL
+=	NULL
se	NULL
&	NULL
Â«	NULL
-	NULL
Â»	NULL
UD	NULL
-	NULL
<	NULL
fos	NULL
188	NULL
Â»	NULL
+o	NULL
4+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
CsA	NULL
=o	NULL
ob	NULL
-	NULL
=o	NULL
of	NULL
-	NULL
Â«	NULL
o	NULL
#	NULL
-	NULL
=-	NULL
+	NULL
-	NULL
ono	NULL
Koe	NULL
$	NULL
o	NULL
00k	NULL
s	NULL
#	NULL
<	NULL
0	NULL
8	NULL
0400	NULL
}	NULL
-	NULL
40	NULL
PMA	NULL
b	NULL
C	NULL
20	NULL
100	NULL
Ju.rkat	NULL
.	NULL

1,141.0	NULL
)	NULL
-	NULL
[	NULL
_J	NULL
]	NULL
CsA	NULL
control	NULL
g	NULL
L_	NULL
]	NULL
control	NULL
0	NULL
*	NULL
e	NULL
@	NULL
Â»	NULL
-	NULL
I	NULL
:	NULL
CsA	NULL
lono	NULL
Q	NULL
|0n0	NULL
tof	NULL
fof	NULL
poos	NULL
-	NULL
CC	NULL
CsA	NULL
PMA	NULL
O	NULL
CZ	NULL
PMA	NULL
15	NULL
|	NULL
~	NULL
C	NULL
+00	NULL
-	NULL
>	NULL
-	NULL
+	NULL
pma	NULL
~-	NULL
RWW	NULL
CsA	NULL
lono+PMA	NULL
C	NULL
|	NULL
RRM	NULL
PMA	NULL
hl	NULL
>	NULL
CS	NULL
3	NULL
6	NULL
o	NULL
A-	NULL
<	NULL
10	NULL
-	NULL
Â©	NULL
50	NULL
0	NULL
-	NULL
a	NULL
<	NULL
L_	NULL
5	NULL
9	NULL
Az	NULL
5	NULL
-	NULL
A	NULL
A	NULL
|_	NULL
<	NULL
(	NULL
an	NULL
Cd	NULL
bal	NULL
'	NULL
7	NULL
L_	NULL
7	NULL
0	NULL
-	NULL
0	NULL
-	NULL
hees	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
Cell	NULL
Line	NULL
Cell	NULL
Line	NULL
d	NULL
of	NULL
0	NULL
98	NULL
``	NULL
50	NULL
yor	NULL
``	NULL
gt	NULL
50Â°	NULL
git	NULL
got	NULL
``	NULL
[	NULL
get	NULL
gan	NULL
CsA	NULL
200	NULL
ng/m	NULL
!	NULL

-	NULL
=	NULL
-	NULL
+	NULL
+0	NULL
+	NULL
>	NULL
-	NULL
-	NULL
+	NULL
40+	NULL
0	NULL
0	NULL
'	NULL
â	NULL
'	NULL
'	NULL
â	NULL
.	NULL

0	NULL
.	NULL

0	NULL
â	NULL
-	NULL
<	NULL
-GDP	NULL
C	NULL
FY	NULL
J	NULL
Â¢	NULL
|	NULL
_	NULL
-	NULL
<	NULL
--	NULL
atP	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
Jurkat	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Restoration	NULL
of	NULL
calcium	NULL
ionophore-induced	NULL
egr-7	NULL
and	NULL
c-fos	NULL
expression	NULL
in	NULL
PH1	NULL
cells	NULL
by	NULL
CsA	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
200	NULL
ng	NULL
of	NULL
CsA	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
and	NULL
stimulated	NULL
with	NULL
2	NULL
M	NULL
calcium	NULL
ionophore	NULL
(	NULL
Iono	NULL
)	NULL
or	NULL
100	NULL
nM	NULL
PMA	NULL
for	NULL
1	NULL
h	NULL
,	NULL
separately	NULL
.	NULL

RNA	NULL
blotting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
c-fos	NULL
and	NULL
egr-1	NULL
expression	NULL
.	NULL

The	NULL
same	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
for	NULL
quantitation	NULL
of	NULL
the	NULL
levels	NULL
of	NULL
c-fos	NULL
transcripts	NULL
.	NULL

This	NULL
blot	NULL
was	NULL
part	NULL
of	NULL
the	NULL
same	NULL
experiment	NULL
and	NULL
blot	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
and	NULL
control	NULL
lanes	NULL
showing	NULL
egr-7	NULL
and	NULL
c-fos	NULL
levels	NULL
in	NULL
untreated	NULL
cells	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

la	NULL
and	NULL
b	NULL
.	NULL

(	NULL
b	NULL
)	NULL
A	NULL
c-fos	NULL
promoter-CAT	NULL
chimeric	NULL
gene	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
either	NULL
Jurkat	NULL
or	NULL
PHI1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
exposed	NULL
to	NULL
CsA	NULL
(	NULL
200	NULL
ng/m	NULL
!	NULL
)	NULL

prior	NULL
to	NULL
and	NULL
during	NULL
the	NULL
stimulations	NULL
.	NULL

After	NULL
being	NULL
stimulated	NULL
as	NULL
indicated	NULL
for	NULL
4	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
assay	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

control	NULL
,	NULL
untreated	NULL
control	NULL
;	NULL
Iono	NULL
,	NULL
2	NULL
M	NULL
calcium	NULL
ionophore	NULL
;	NULL
PMA	NULL
,	NULL
100	NULL
nM	NULL
PMA	NULL
;	NULL
Iono	NULL
+	NULL
PMA	NULL
,	NULL
100	NULL
nM	NULL
PMA	NULL
plus	NULL
2	NULL
wM	NULL
calcium	NULL
ionophore	NULL
.	NULL

Standard	NULL
error	NULL
bars	NULL
are	NULL
shown	NULL
.	NULL

Cotransfections	NULL
with	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
B-galactosidase	NULL
vector	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
verified	NULL
equivalent	NULL
efficiencies	NULL
of	NULL
transfection	NULL
.	NULL

The	NULL
inset	NULL
is	NULL
an	NULL
autoradiogram	NULL
of	NULL
the	NULL
same	NULL
type	NULL
of	NULL
experiment	NULL
,	NULL
but	NULL
one	NULL
in	NULL
which	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
chromatography	NULL
rather	NULL
than	NULL
by	NULL
organic	NULL
extraction	NULL
.	NULL

The	NULL
control	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
cells	NULL
were	NULL
not	NULL
treated	NULL
with	NULL
CsA	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1Â¢c	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Constitutive	NULL
and	NULL
stimulated	NULL
MAP	NULL
kinase	NULL
activity	NULL
.	NULL

The	NULL
relative	NULL
Â°Â°P	NULL
incorporation	NULL
into	NULL
a	NULL
MAP	NULL
kinase-specific	NULL
substrate	NULL
(	NULL
MBP	NULL
)	NULL
was	NULL
used	NULL
to	NULL
quantitate	NULL
MAP	NULL
kinase	NULL
phosphotransferase	NULL
activity	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
the	NULL
standard	NULL
deviations	NULL
over	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

control	NULL
,	NULL
untreated	NULL
cells	NULL
;	NULL
Jono	NULL
,	NULL
2	NULL
wM	NULL
calcium	NULL
ionophore	NULL
;	NULL
PMA	NULL
,	NULL
100	NULL
nM	NULL
PMA	NULL
;	NULL
Iono	NULL
+	NULL
PMA	NULL
,	NULL
100	NULL
nM	NULL
PMA	NULL
plus	NULL
2	NULL
M	NULL
calcium	NULL
ionophore	NULL
.	NULL

(	NULL
d	NULL
)	NULL
p21	NULL
``	NULL
``	NULL
activation	NULL
in	NULL
Jurkat	NULL
and	NULL
PH1	NULL
cells	NULL
after	NULL
inhibition	NULL
of	NULL
calcineurin	NULL
activity	NULL
.	NULL

After	NULL
inhibition	NULL
of	NULL
calcineurin	NULL
by	NULL
CsA	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
100	NULL
nM	NULL
PMA	NULL
or	NULL
2	NULL
wM	NULL
Ca	NULL
**	NULL
ionophore	NULL
for	NULL
10	NULL
min	NULL
and	NULL
immunoprecipitated	NULL
p21	NULL
``	NULL
was	NULL
assayed	NULL
for	NULL
GTP/GDP	NULL
ratios	NULL
.	NULL

Contl	NULL
,	NULL
control	NULL
.	NULL

unstimulated	NULL
levels	NULL
)	NULL
,	NULL
peaking	NULL
at	NULL
6	NULL
to	NULL
8	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

In	NULL
fold	NULL
)	NULL
was	NULL
seen	NULL
at	NULL
later	NULL
time	NULL
points	NULL
.	NULL

The	NULL
relatively	NULL
low	NULL
amount	NULL
contrast	NULL
,	NULL
in	NULL
PH1	NULL
cells	NULL
,	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
peaked	NULL
at	NULL
of	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
seen	NULL
at	NULL
8	NULL
h	NULL
after	NULL
stimulation	NULL
may	NULL
2	NULL
h	NULL
poststimulation	NULL
(	NULL
by	NULL
2-fold	NULL
over	NULL
that	NULL
of	NULL
the	NULL
unstimulated	NULL
therefore	NULL
be	NULL
the	NULL
consequence	NULL
of	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
cell	NULL
to	NULL
control	NULL
)	NULL
and	NULL
attenuation	NULL
of	NULL
the	NULL
DNA-binding	NULL
(	NULL
by	NULL
0.8-	NULL
to	NULL
1.2-	NULL
recruit	NULL
newly	NULL
synthesized	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
members	NULL
at	NULL
later	NULL
6588	NULL
CHEN	NULL
ET	NULL
AL	NULL
.	NULL

a	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
28Â§S-Â®	NULL
_	NULL
,	NULL
P	NULL
Â®	NULL
``	NULL
Â«	NULL
|	NULL
te	NULL
.	NULL

*	NULL
M	NULL
Â«	NULL
#	NULL
%	NULL
d	NULL
We	NULL
(	NULL
*~	NULL
WB	NULL
-	NULL
<	NULL
jun	NULL
188-	NULL
Â»	NULL
.	NULL

E	NULL
*	NULL
aan	NULL
an	NULL
a	NULL
-o-	NULL
-	NULL
toot	NULL
oo	NULL
#	NULL
-o	NULL
-	NULL
-	NULL
to	NULL
+	NULL
CsA	NULL
ook	NULL
oR	NULL
&	NULL
#	NULL
ok	NULL
=-	NULL
+	NULL
-	NULL
o-	NULL
+	NULL
-	NULL
lono	NULL
Kok	NULL
400k	NULL
}	NULL
+	NULL
#	NULL
-o	NULL
-	NULL
4	NULL
}	NULL
-	NULL
+	NULL
PMA	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

b	NULL
Neo	NULL
PH1	NULL
(	NULL
19	NULL
)	NULL
-t	NULL
Â»	NULL
Â«	NULL
o	NULL
to	NULL
_	NULL
#	NULL
tp	NULL
(	NULL
td	NULL
tp	NULL
<	NULL
-	NULL
jun	NULL
18Â§	NULL
-	NULL
Â»	NULL
o-	NULL
e	NULL
4	NULL
40+	NULL
oe	NULL
e	NULL
0	NULL
oto	NULL
4	NULL
+	NULL
CsA	NULL
-o4	NULL
&	NULL
-	NULL
-o+	NULL
-	NULL
--	NULL
+	NULL
-	NULL
dono	NULL
wo	NULL
e	NULL
ook	NULL
4	NULL
#	NULL
-o	NULL
-	NULL
R	NULL
o	NULL
o-	NULL
-	NULL
4	NULL
PMA	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Induction	NULL
of	NULL
c-gun	NULL
transcript	NULL
expression	NULL
by	NULL
calcium	NULL
ionophore	NULL
(	NULL
Iono	NULL
)	NULL
or	NULL
PMA	NULL
,	NULL
with	NULL
or	NULL
without	NULL
CsA	NULL
treatment	NULL
.	NULL

Jurkat	NULL
,	NULL
Neo	NULL
,	NULL
and	NULL
PH1	NULL
clone	NULL
7	NULL
and	NULL
19	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
200	NULL
ng	NULL
of	NULL
CsA	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
or	NULL
left	NULL
untreated	NULL
and	NULL
stimulated	NULL
with	NULL
calcium	NULL
ionophore	NULL
or	NULL
PMA	NULL
for	NULL
40	NULL
min	NULL
.	NULL

RNAs	NULL
were	NULL
harvested	NULL
and	NULL
c-jun	NULL
transcripts	NULL
were	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

Autoradiograms	NULL
are	NULL
shown	NULL
here	NULL
.	NULL

time	NULL
points	NULL
to	NULL
sustain	NULL
the	NULL
AP-1	NULL
complex	NULL
activity	NULL
,	NULL
itself	NULL
the	NULL
consequence	NULL
of	NULL
negative	NULL
regulation	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
induction	NULL
by	NULL
activated	NULL
p21	NULL
``	NULL
``	NULL
.	NULL

The	NULL
downstream	NULL
events	NULL
in	NULL
T-cell	NULL
activation	NULL
which	NULL
require	NULL
AP-1	NULL
activity	NULL
include	NULL
IL-2	NULL
production	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
differences	NULL
in	NULL
inducible	NULL
AP-1	NULL
DNA-binding	NULL
activities	NULL
in	NULL
PH1	NULL
cells	NULL
had	NULL
any	NULL
effect	NULL
on	NULL
later	NULL
activation	NULL
events	NULL
,	NULL
IL-2	NULL
gene	NULL
induction	NULL
and	NULL
IL-2	NULL
protein	NULL
production	NULL
were	NULL
assayed	NULL
.	NULL

Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
calcium	NULL
ionophore	NULL
plus	NULL
PMA	NULL
for	NULL
8	NULL
,	NULL
10	NULL
,	NULL
or	NULL
12	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

6a	NULL
)	NULL
.	NULL

The	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
IL-2	NULL
gene	NULL
induction	NULL
was	NULL
quantitated	NULL
.	NULL

IL-2	NULL
gene	NULL
transcripts	NULL
were	NULL
strongly	NULL
and	NULL
consistently	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
at	NULL
8	NULL
to	NULL
12	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
PHI1	NULL
cells	NULL
started	NULL
to	NULL
fall	NULL
at	NULL
10	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
was	NULL
almost	NULL
undetectable	NULL
at	NULL
12	NULL
h.	NULL
To	NULL
measure	NULL
IL-2	NULL
protein	NULL
production	NULL
at	NULL
later	NULL
times	NULL
after	NULL
activation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
calcium	NULL
ionophore	NULL
.	NULL

At	NULL
12	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
media	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
changed	NULL
,	NULL
and	NULL
then	NULL
the	NULL
media	NULL
were	NULL
collected	NULL
at	NULL
24	NULL
h	NULL
to	NULL
assess	NULL
IL-2	NULL
production	NULL
between	NULL
12	NULL
and	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
or	NULL
at	NULL
36	NULL
h	NULL
to	NULL
assess	NULL
IL-2	NULL
production	NULL
between	NULL
12	NULL
and	NULL
36	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

The	NULL
conditioned	NULL
media	NULL
were	NULL
analyzed	NULL
by	NULL
ELISA	NULL
for	NULL
their	NULL
concentrations	NULL
of	NULL
IL-2	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

6b	NULL
)	NULL
.	NULL

The	NULL
production	NULL
of	NULL
IL-2	NULL
protein	NULL
increased	NULL
over	NULL
the	NULL
time	NULL
intervals	NULL
examined	NULL
in	NULL
Jurkat	NULL
cells	NULL
but	NULL
decreased	NULL
in	NULL
PHI1	NULL
cells	NULL
over	NULL
the	NULL
same	NULL
period	NULL
.	NULL

Stimulated	NULL
IL-2	NULL
production	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
activated	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
was	NULL
therefore	NULL
not	NULL
sustained	NULL
in	NULL
comparison	NULL
with	NULL
IL-2	NULL
production	NULL
in	NULL
parental	NULL
or	NULL
control-transfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
temporal	NULL
and	NULL
quantitative	NULL
differences	NULL
in	NULL
IL-2	NULL
production	NULL
caused	NULL
by	NULL
activated	NULL
p21	NULL
``	NULL
,	NULL
together	NULL
with	NULL
the	NULL
discrepant	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
paralleled	NULL
the	NULL
results	NULL
obtained	NULL
when	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
was	NULL
examined	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

DISCUSSION	NULL
T	NULL
lymphocytes	NULL
are	NULL
induced	NULL
to	NULL
secrete	NULL
lymphokines	NULL
,	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
proliferate	NULL
when	NULL
an	NULL
appropriate	NULL
antigenic	NULL
stimulus	NULL
is	NULL
presented	NULL
to	NULL
their	NULL
surface	NULL
membrane	NULL
TcRs	NULL
(	NULL
24	NULL
,	NULL
83	NULL
)	NULL
.	NULL

One	NULL
important	NULL
sequela	NULL
of	NULL
TeR	NULL
stimulation	NULL
is	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
SOS	NULL
activity	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
GTP	NULL
bound	NULL
to	NULL
p21	NULL
``	NULL
.	NULL

This	NULL
p21	NULL
``	NULL
*-regulated	NULL
signaling	NULL
cascade	NULL
is	NULL
essential	NULL
for	NULL
T-cell	NULL
activation	NULL
(	NULL
19	NULL
,	NULL
29	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
other	NULL
cell	NULL
lineages	NULL
(	NULL
53	NULL
,	NULL
68	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
constitutively	NULL
activated	NULL
p21	NULL
``	NULL
can	NULL
augment	NULL
the	NULL
T-cell	NULL
immunological	NULL
response	NULL
,	NULL
in	NULL
terms	NULL
of	NULL
IL-2	NULL
production	NULL
,	NULL
at	NULL
early	NULL
periods	NULL
(	NULL
up	NULL
to	NULL
12	NULL
h	NULL
)	NULL
after	NULL
stimulation	NULL
(	NULL
11a	NULL
)	NULL
.	NULL

This	NULL
synergistic	NULL
effect	NULL
may	NULL
be	NULL
achieved	NULL
through	NULL
the	NULL
interaction	NULL
between	NULL
activated	NULL
p21	NULL
``	NULL
and	NULL
calcineurin	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
9a	NULL
,	NULL
87	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
that	NULL
p21	NULL
``	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
negative	NULL
feedback	NULL
attenuation	NULL
mechanisms	NULL
or	NULL
desensitization	NULL
processes	NULL
,	NULL
as	NULL
a	NULL
part	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
activation	NULL
,	NULL
perhaps	NULL
to	NULL
control	NULL
or	NULL
limit	NULL
superfluous	NULL
or	NULL
redundant	NULL
incoming	NULL
signals	NULL
(	NULL
59	NULL
,	NULL
65	NULL
,	NULL
80	NULL
,	NULL
82	NULL
,	NULL
89	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
such	NULL
activation	NULL
responses	NULL
or	NULL
feedback	NULL
attenuations	NULL
regulated	NULL
by	NULL
p21	NULL
``	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
negative	NULL
modulatory	NULL
signals	NULL
transmitted	NULL
by	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
and	NULL
how	NULL
cross-talk	NULL
of	NULL
signals	NULL
transduced	NULL
by	NULL
p21	NULL
``	NULL
modulates	NULL
the	NULL
magnitude	NULL
of	NULL
ongoing	NULL
signals	NULL
.	NULL

In	NULL
Drosophila	NULL
melanogaster	NULL
,	NULL
activated	NULL
Ras	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
negatively	NULL
regulate	NULL
yan	NULL
function	NULL
,	NULL
modulating	NULL
the	NULL
magnitude	NULL
of	NULL
signals	NULL
,	NULL
and	NULL
this	NULL
appears	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
differentiation	NULL
of	NULL
neuronal	NULL
and	NULL
nonneuronal	NULL
tissues	NULL
during	NULL
developmental	NULL
stages	NULL
(	NULL
62	NULL
,	NULL
66	NULL
)	NULL
.	NULL

Similar	NULL
negative	NULL
modulatory	NULL
functions	NULL
of	NULL
p21	NULL
``	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
thoroughly	NULL
investigated	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
constitutive	NULL
expression	NULL
of	NULL
activated	NULL
p21	NULL
``	NULL
,	NULL
perhaps	NULL
through	NULL
an	NULL
interaction	NULL
with	NULL
calcineurin	NULL
,	NULL
blocks	NULL
calcium-dependent	NULL
IE	NULL
gene	NULL
induction	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
,	NULL
longer	NULL
term	NULL
,	NULL
by	NULL
attenuation	NULL
of	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
and	NULL
IL-2	NULL
production	NULL
,	NULL
inhibits	NULL
or	NULL
limits	NULL
an	NULL
immunological	NULL
response	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
serving	NULL
as	NULL
a	NULL
critical	NULL
signal	NULL
transducer	NULL
during	NULL
activation	NULL
,	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
appears	NULL
to	NULL
be	NULL
directly	NULL
or	NULL
indirectly	NULL
involved	NULL
in	NULL
mediating	NULL
at	NULL
least	NULL
two	NULL
different	NULL
types	NULL
of	NULL
negative	NULL
regulation	NULL
:	NULL
feedback	NULL
attenuation	NULL
control	NULL
and	NULL
negative	NULL
regulatory	NULL
modulation	NULL
.	NULL

The	NULL
positive	NULL
actions	NULL
of	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
,	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
35	NULL
,	NULL
51	NULL
,	NULL
53	NULL
,	NULL
87	NULL
)	NULL
,	NULL
are	NULL
intrinsic	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
responses	NULL
to	NULL
external	NULL
stimuli	NULL
.	NULL

Through	NULL
the	NULL
interaction	NULL
with	NULL
its	NULL
downstream	NULL
molecules	NULL
,	NULL
p21	NULL
``	NULL
elicits	NULL
certain	NULL
genetic	NULL
programs	NULL
which	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
activation	NULL
or	NULL
growth	NULL
(	NULL
35	NULL
,	NULL
53	NULL
)	NULL
and	NULL
,	NULL
in	NULL
some	NULL
cases	NULL
,	NULL
which	NULL
may	NULL
cause	NULL
cell	NULL
transformation	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
demonstrated	NULL
such	NULL
a	NULL
positive	NULL
action	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
,	NULL
which	NULL
is	NULL
manifested	NULL
as	NULL
a	NULL
synergistic	NULL
increase	NULL
in	NULL
the	NULL
stimulated	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-AT	NULL
under	NULL
certain	NULL
conditions	NULL
,	NULL
coordinate	NULL
with	NULL
a	NULL
transient	NULL
augmentation	NULL
of	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
and	NULL
IL-2	NULL
production	NULL
(	NULL
9a	NULL
)	NULL
.	NULL

Feedback	NULL
attenuation	NULL
or	NULL
desensitization	NULL
of	NULL
incoming	NULL
mitogenic	NULL
or	NULL
growth-related	NULL
signals	NULL
by	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
,	NULL
in	NULL
which	NULL
the	NULL
activated	NULL
p21	NULL
``	NULL
``	NULL
interferes	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
upstream	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
type-B	NULL
receptor	NULL
(	NULL
65	NULL
,	NULL
80	NULL
,	NULL
89	NULL
)	NULL
,	NULL
double-stranded	NULL
RNA-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
PKR	NULL
)	NULL
(	NULL
59	NULL
)	NULL
,	NULL
and	NULL
SOS	NULL
(	NULL
82	NULL
)	NULL
,	NULL
so	NULL
as	NULL
to	NULL
diminish	NULL
or	NULL
block	NULL
the	NULL
signal	NULL
transmission	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
model	NULL
of	NULL
feedback	NULL
attenuation	NULL
control	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
activated	NULL
p21	NULL
``	NULL
may	NULL
also	NULL
activate	NULL
or	NULL
mediate	NULL
a	NULL
negative	NULL
regulatory	NULL
function	NULL
,	NULL
through	NULL
which	NULL
the	NULL
magnitude	NULL
of	NULL
ongoing	NULL
signals	NULL
are	NULL
negatively	NULL
modified	NULL
in	NULL
parallel	NULL
with	NULL
an	NULL
activation	NULL
process	NULL
,	NULL
perhaps	NULL
to	NULL
prevent	NULL
overshoot	NULL
and	NULL
to	NULL
maintain	NULL
the	NULL
competence	NULL
of	NULL
a	NULL
cell	NULL
for	NULL
further	NULL
respon-siveness	NULL
.	NULL

One	NULL
arm	NULL
of	NULL
the	NULL
T-cell-activation	NULL
signal	NULL
negatively	NULL
regulated	NULL
by	NULL
p21	NULL
``	NULL
``	NULL
is	NULL
the	NULL
calcium-activated	NULL
pathway	NULL
studied	NULL
here	NULL
,	NULL
which	NULL
is	NULL
independent	NULL
of	NULL
PKC	NULL
signals	NULL
.	NULL

Activated	NULL
Ras	NULL
,	NULL
perhaps	NULL
through	NULL
an	NULL
as	NULL
yet	NULL
undefined	NULL
mechanism	NULL
,	NULL
interacts	NULL
with	NULL
the	NULL
activating	NULL
signal	NULL
generated	NULL
by	NULL
calcium	NULL
to	NULL
mediate	NULL
the	NULL
neg-	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
a	NULL
PK	NULL
@	NULL
a	NULL
a	NULL
69	NULL
6Â°	NULL
Â®	NULL
oÂ°Â¢	NULL
Â©	NULL
009	NULL
,	NULL
C	NULL
Â«	NULL
&	NULL
Â©	NULL
-	NULL
&	NULL
oÂ°tb	NULL
Â«	NULL
Â°	NULL
C	NULL
-	NULL
C	NULL
ECO	NULL
C	NULL
.Â°	NULL
y	NULL
``	NULL
y	NULL
``	NULL
&	NULL
<	NULL
2	NULL
â	NULL
&	NULL
&	NULL
&	NULL
ï¬	NULL
W	NULL
â	NULL
-	NULL
<	NULL
-AP-1	NULL
-C	NULL
&	NULL
Q	NULL
â	NULL
s	NULL
â	NULL
Q	NULL
â	NULL
s	NULL
â	NULL
Â®	NULL
``	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
b	NULL
00Â°	NULL
06Â°	NULL
&	NULL
00	NULL
06Â°	NULL
Â®	NULL
0	NULL
0	NULL
A	NULL
00Â°	NULL
39Â°	NULL
00Â°	NULL
&	NULL
00Â°	NULL
39Â°	NULL
x\Â°Â°	NULL
8	NULL
aP	NULL
aP	NULL
ar	NULL
&	NULL
aFr	NULL
aP	NULL
ar	NULL
Â¢	NULL
C	NULL
8C	NULL
Â§	NULL
9	NULL
5	NULL
Â¢	NULL
H	NULL
â	NULL
-	NULL
<	NULL
-NF-AT	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
C	NULL
$	NULL
339	NULL
&	NULL
6:80	NULL
Â®	NULL
_C	NULL
,	NULL
&	NULL
9	NULL
&	NULL
9	NULL
&	NULL
Om	NULL
of	NULL
Â»	NULL
Om	NULL
o	NULL
0	NULL
0	NULL
â	NULL
1	NULL
'	NULL
900	NULL
x\Â°Â°	NULL
x\Â°Â°	NULL
\Â°o	NULL
x90	NULL
â	NULL
sC	NULL
y	NULL
8g	NULL
-	NULL
&	NULL
$	NULL
g	NULL
Cy	NULL
C3	NULL
$	NULL
00	NULL
Â»	NULL
``	NULL
&	NULL
Â«	NULL
00Â°	NULL
&	NULL
&	NULL
00Â°	NULL
â	NULL
Q6	NULL
?	NULL

ar	NULL
Q	NULL
â	NULL
s	NULL
?	NULL

0Â°Â°\	NULL
Q6	NULL
?	NULL

Q	NULL
â	NULL
s	NULL
}	NULL
Q6	NULL
?	NULL

-	NULL
<	NULL
Â«	NULL
+-	NULL
NFKB	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
d	NULL
&	NULL
_	NULL
<	NULL
0	NULL
(	NULL
0	NULL
(	NULL
o	NULL
0	NULL
NC	NULL
X\Â°Â°	NULL
x\Â°Â°	NULL
)	NULL
<	NULL
\Â°o	NULL
A	NULL
X\Â°Â°	NULL
x\Â°Â°	NULL
x\Â°Q	NULL
â¬	NULL
ar	NULL
ar	NULL
_	NULL
â¬	NULL
ar	NULL
ar	NULL
r	NULL
o	NULL
M	NULL
wous	NULL
Sumi	NULL
)	NULL
wud	NULL
-	NULL
<	NULL
-Oct-1	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
transcriptional	NULL
factors	NULL
mediating	NULL
IL-2	NULL
induction	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
and	NULL
PH1	NULL
cells	NULL
stimulated	NULL
with	NULL
2	NULL
wM	NULL
calcium	NULL
ionophore	NULL
plus	NULL
100	NULL
nM	NULL
PMA	NULL
for	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
h	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
AP-1	NULL
binding	NULL
site	NULL
.	NULL

An	NULL
EMSA	NULL
was	NULL
performed	NULL
.	NULL

Results	NULL
of	NULL
EMSA	NULL
using	NULL
an	NULL
NF-AT	NULL
site	NULL
(	NULL
b	NULL
)	NULL
,	NULL
an	NULL
NF-	NULL
Â«	NULL
B	NULL
site	NULL
(	NULL
c	NULL
)	NULL
,	NULL
and	NULL
an	NULL
Oct-1	NULL
site	NULL
(	NULL
d	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Contl	NULL
,	NULL
control	NULL
.	NULL

ative	NULL
regulation	NULL
of	NULL
IE	NULL
genes	NULL
.	NULL

One	NULL
signaling	NULL
molecule	NULL
which	NULL
may	NULL
be	NULL
unique	NULL
to	NULL
the	NULL
Ca	NULL
**	NULL
pathway	NULL
is	NULL
the	NULL
calcium-dependent	NULL
protein	NULL
phosphatase	NULL
calcineurin	NULL
,	NULL
a	NULL
molecule	NULL
critical	NULL
to	NULL
T-cell-activation	NULL
pathways	NULL
.	NULL

The	NULL
suppression	NULL
by	NULL
CsA	NULL
of	NULL
the	NULL
p21	NULL
``	NULL
``	NULL
inhibitory	NULL
activity	NULL
on	NULL
induction	NULL
of	NULL
and	NULL
c-fos	NULL
by	NULL
calcium	NULL
suggested	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
calcineurin	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
presented	NULL
evidence	NULL
that	NULL
activated	NULL
p21	NULL
``	NULL
renders	NULL
T	NULL
lymphocytes	NULL
more	NULL
resistant	NULL
to	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
CsA	NULL
on	NULL
NEGATIVE	NULL
REGULATION	NULL
OF	NULL
IE	NULL
GENE	NULL
EXPRESSION	NULL
BY	NULL
Ras	NULL
6589	NULL
NF-AT	NULL
activation	NULL
(	NULL
9a	NULL
)	NULL
.	NULL

We	NULL
speculated	NULL
that	NULL
this	NULL
increased	NULL
resistance	NULL
to	NULL
CsA	NULL
imparted	NULL
by	NULL
activated	NULL
p21	NULL
``	NULL
may	NULL
reflect	NULL
an	NULL
augmentation	NULL
of	NULL
calcineurin	NULL
activity	NULL
.	NULL

That	NULL
is	NULL
,	NULL
activated	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
appears	NULL
to	NULL
directly	NULL
or	NULL
indirectly	NULL
promote	NULL
or	NULL
prolong	NULL
the	NULL
activity	NULL
of	NULL
calcineurin	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
may	NULL
negatively	NULL
regulate	NULL
some	NULL
signaling	NULL
pathways	NULL
while	NULL
activating	NULL
others	NULL
.	NULL

Thus	NULL
,	NULL
calcineurin	NULL
may	NULL
play	NULL
a	NULL
crucial	NULL
dual	NULL
function	NULL
in	NULL
mediating	NULL
both	NULL
the	NULL
positive	NULL
and	NULL
the	NULL
negative	NULL
regulatory	NULL
activities	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
CsA	NULL
to	NULL
reverse	NULL
inhibition	NULL
of	NULL
calcium-mediated	NULL
c-jun	NULL
expression	NULL
by	NULL
activated	NULL
Ras	NULL
suggests	NULL
the	NULL
existence	NULL
of	NULL
another	NULL
,	NULL
distinct	NULL
negatlve	NULL
regulatory	NULL
pathway	NULL
in	NULL
which	NULL
p21	NULL
``	NULL
is	NULL
involved	NULL
but	NULL
which	NULL
is	NULL
,	NULL
in	NULL
this	NULL
case	NULL
,	NULL
independent	NULL
of	NULL
calcineurin	NULL
activity	NULL
.	NULL

The	NULL
transforming	NULL
growth	NULL
factor	NULL
B1	NULL
receptor	NULL
and	NULL
T-cell	NULL
activation-related	NULL
coreceptor	NULL
CTLA-4	NULL
are	NULL
cell-surface	NULL
molecules	NULL
which	NULL
are	NULL
able	NULL
to	NULL
generate	NULL
negative	NULL
signals	NULL
along	NULL
with	NULL
mitogenic	NULL
or	NULL
stimulatory	NULL
ones	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
negative	NULL
modulation	NULL
by	NULL
p21	NULL
``	NULL
is	NULL
involved	NULL
in	NULL
such	NULL
regulatory	NULL
pathways	NULL
.	NULL

The	NULL
full	NULL
effects	NULL
of	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
Ca	NULL
**	NULL
-activat-ed	NULL
IE	NULL
gene	NULL
induction	NULL
pathway	NULL
on	NULL
T-cell	NULL
activation	NULL
are	NULL
yet	NULL
to	NULL
be	NULL
completely	NULL
defined	NULL
,	NULL
but	NULL
one	NULL
potentially	NULL
important	NULL
consequence	NULL
follows	NULL
from	NULL
the	NULL
effects	NULL
on	NULL
c-jun	NULL
and	NULL
c-fos	NULL
gene	NULL
induction	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-1	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
IL-2	NULL
a	NULL
Q	NULL
,	NULL
â	NULL
N60	NULL
(	NULL
to	NULL
Q	NULL
)	NULL
â	NULL
60	NULL
60:0	NULL
\0	NULL
â	NULL
x	NULL
â	NULL
\0	NULL
â	NULL
Â°	NULL
3	NULL
\0Â°	NULL
w	NULL
``	NULL
,	NULL
~	NULL
``	NULL
P	NULL
coÂ®	NULL
9s	NULL
?	NULL

gpa	NULL
``	NULL
Q	NULL
â	NULL
s	NULL
â	NULL
Q9	NULL
â	NULL
gs	NULL
``	NULL
pa	NULL
Â«	NULL
o	NULL
Â«	NULL
p	NULL
cn	NULL
emp	NULL
Â«	NULL
Â«	NULL
Â»	NULL
-	NULL
<	NULL
-	NULL
IL-2	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
b	NULL
0.5	NULL
El	NULL
Ctrl	NULL
(	NULL
72	NULL
)	NULL
12-24h	NULL
0.4	NULL
U	NULL
1	NULL
Â»	NULL
-s5	NULL
2	NULL
0.3	NULL
{	NULL
C	NULL
3	NULL
o	NULL
o	NULL
0.2	NULL
0.1	NULL
0.0	NULL
7	NULL
Jurkat	NULL
PH1	NULL
(	NULL
7	NULL
)	NULL
Cell	NULL
Line	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

RNA	NULL
blot	NULL
analysis	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
Jurkat	NULL
and	NULL
PH1	NULL
(	NULL
clone	NULL
7	NULL
)	NULL
cells	NULL
and	NULL
ELISA	NULL
for	NULL
quantitation	NULL
of	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
protein	NULL
at	NULL
various	NULL
times	NULL
after	NULL
stimulation	NULL
.	NULL

(	NULL
a	NULL
)	NULL
The	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNAs	NULL
were	NULL
isolated	NULL
,	NULL
separated	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
Â°Â°P-labeled	NULL
human	NULL
ZL-2	NULL
probe	NULL
.	NULL

Equal	NULL
loadings	NULL
of	NULL
total	NULL
mRNAs	NULL
into	NULL
the	NULL
lanes	NULL
of	NULL
the	NULL
gel	NULL
were	NULL
ensured	NULL
by	NULL
rehybridization	NULL
of	NULL
the	NULL
blot	NULL
with	NULL
a	NULL
radiolabeled	NULL
probe	NULL
for	NULL
B-actin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Conditioned	NULL
media	NULL
from	NULL
cells	NULL
were	NULL
collected	NULL
at	NULL
intervals	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
Ca	NULL
**	NULL
ionophore	NULL
(	NULL
12	NULL
to	NULL
24	NULL
and	NULL
12	NULL
to	NULL
36	NULL
h	NULL
)	NULL
after	NULL
an	NULL
initial	NULL
change	NULL
of	NULL
medium	NULL
at	NULL
12	NULL
h.	NULL
Subsequently	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
subjected	NULL
to	NULL
ELISA	NULL
for	NULL
IL-2	NULL
quantitation	NULL
.	NULL

The	NULL
units	NULL
on	NULL
the	NULL
vertical	NULL
axis	NULL
represent	NULL
the	NULL
optical	NULL
densities	NULL
(	NULL
O.D	NULL
.	NULL
)	NULL

of	NULL
ELISA	NULL
samples	NULL
.	NULL

Ctrl	NULL
,	NULL
control	NULL
.	NULL

6590	NULL
CHEN	NULL
ET	NULL
AL	NULL
.	NULL

induction	NULL
,	NULL
the	NULL
hallmark	NULL
of	NULL
T-cell	NULL
activation	NULL
(	NULL
36	NULL
,	NULL
45	NULL
,	NULL
71	NULL
)	NULL
,	NULL
and	NULL
may	NULL
itself	NULL
also	NULL
be	NULL
a	NULL
target	NULL
for	NULL
mediation	NULL
of	NULL
T-cell	NULL
clonal	NULL
anergy	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
Jun-Jun	NULL
family	NULL
ho-modimers	NULL
or	NULL
Fos-Jun	NULL
family	NULL
heterodimers	NULL
.	NULL

The	NULL
decline	NULL
in	NULL
the	NULL
level	NULL
of	NULL
AP-1	NULL
activity	NULL
we	NULL
observed	NULL
after	NULL
8	NULL
h	NULL
poststimulation	NULL
in	NULL
cells	NULL
expressing	NULL
activated	NULL
p21	NULL
``	NULL
correlated	NULL
well	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
IE	NULL
gene	NULL
induction	NULL
by	NULL
p21	NULL
``	NULL
``	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
a	NULL
potential	NULL
mechanism	NULL
mediating	NULL
immunoanergy	NULL
in	NULL
which	NULL
abnormal	NULL
regulation	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
activity	NULL
may	NULL
result	NULL
in	NULL
an	NULL
immune	NULL
unresponsiveness	NULL
,	NULL
via	NULL
attenuation	NULL
of	NULL
the	NULL
magnitude	NULL
and	NULL
duration	NULL
of	NULL
AP-1	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
T-cell-specific	NULL
transcription	NULL
factor	NULL
NF-ATp	NULL
,	NULL
which	NULL
complexes	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
as	NULL
their	NULL
nuclear	NULL
component	NULL
to	NULL
regulate	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
was	NULL
unaffected	NULL
by	NULL
activated	NULL
Ras	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
individual	NULL
nuclear	NULL
components	NULL
of	NULL
the	NULL
final	NULL
complete	NULL
NF-AT	NULL
transcription	NULL
complex	NULL
may	NULL
at	NULL
times	NULL
be	NULL
lim-iting	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
egr-7	NULL
is	NULL
a	NULL
ubiquitous	NULL
effect	NULL
of	NULL
mitogenic	NULL
stimulation	NULL
and	NULL
in	NULL
some	NULL
cases	NULL
accompanies	NULL
cell	NULL
differentiation	NULL
(	NULL
17	NULL
,	NULL
41	NULL
,	NULL
47	NULL
,	NULL
50	NULL
,	NULL
76	NULL
,	NULL
79	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
egr-1	NULL
in	NULL
signal	NULL
transduction	NULL
is	NULL
poorly	NULL
understood	NULL
,	NULL
however	NULL
,	NULL
and	NULL
it	NULL
is	NULL
therefore	NULL
difficult	NULL
to	NULL
predict	NULL
the	NULL
impact	NULL
of	NULL
the	NULL
negative	NULL
regulation	NULL
of	NULL
egr-7	NULL
induction	NULL
by	NULL
p21	NULL
``	NULL
on	NULL
T-cell	NULL
signaling	NULL
.	NULL

Induction	NULL
of	NULL
IE	NULL
genes	NULL
by	NULL
calcium	NULL
alone	NULL
has	NULL
not	NULL
been	NULL
thoroughly	NULL
studied	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
our	NULL
unpublished	NULL
work	NULL
indicates	NULL
that	NULL
calcium	NULL
ionophore	NULL
does	NULL
not	NULL
induce	NULL
the	NULL
same	NULL
set	NULL
of	NULL
IE	NULL
genes	NULL
in	NULL
fibroblasts	NULL
.	NULL

c-fos	NULL
induction	NULL
by	NULL
calcium	NULL
in	NULL
a	NULL
pheochromocytoma	NULL
cell	NULL
line	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
a	NULL
calmodulin	NULL
kinase	NULL
II-dependent	NULL
pathway	NULL
and	NULL
the	NULL
cAMP-responsive	NULL
binding	NULL
protein	NULL
CREB	NULL
(	NULL
57	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
dibutyryl	NULL
cAMP	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
or	NULL
forskolin	NULL
(	NULL
an	NULL
activator	NULL
of	NULL
PKA	NULL
)	NULL
did	NULL
not	NULL
induce	NULL
egr-7	NULL
in	NULL
lymphocytes	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
protein	NULL
kinase	NULL
A	NULL
inhibitor	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
genes	NULL
by	NULL
calcium	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
11b	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
elements	NULL
of	NULL
these	NULL
IE	NULL
genes	NULL
responsible	NULL
for	NULL
lin-eage-specific	NULL
induction	NULL
by	NULL
calcium	NULL
are	NULL
currently	NULL
under	NULL
investi-gation	NULL
.	NULL

Calmodulin	NULL
is	NULL
the	NULL
major	NULL
intracellular	NULL
calcium	NULL
receptor	NULL
.	NULL

Calmodulin	NULL
binds	NULL
to	NULL
and	NULL
directly	NULL
regulates	NULL
the	NULL
activities	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
enzymes	NULL
,	NULL
including	NULL
the	NULL
calmodulin	NULL
kinases	NULL
,	NULL
the	NULL
protein	NULL
phosphatases	NULL
,	NULL
calcineurin	NULL
,	NULL
and	NULL
protein	NULL
phosphatase	NULL
2A	NULL
.	NULL

The	NULL
best-characterized	NULL
calcium-activated	NULL
signals	NULL
in	NULL
the	NULL
T-cell	NULL
signal	NULL
transduction	NULL
cascade	NULL
leading	NULL
to	NULL
IL-2	NULL
gene	NULL
induction	NULL
are	NULL
mediated	NULL
through	NULL
calcineurin	NULL
.	NULL

CsA	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
calcineurin	NULL
,	NULL
did	NULL
not	NULL
inhibit	NULL
induction	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
by	NULL
calcium	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
inhibitors	NULL
of	NULL
PKC	NULL
,	NULL
calmodulin	NULL
kinase	NULL
II	NULL
,	NULL
or	NULL
calcineurin	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
by	NULL
ionophore	NULL
in	NULL
Jurkat	NULL
cells	NULL
indicates	NULL
that	NULL
these	NULL
particular	NULL
calcium-activated	NULL
enzymes	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
this	NULL
pathway	NULL
.	NULL

Inhibitors	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
were	NULL
also	NULL
ineffective	NULL
in	NULL
blocking	NULL
IE	NULL
gene	NULL
induction	NULL
by	NULL
calcium	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

While	NULL
the	NULL
expression	NULL
of	NULL
p21	NULL
``	NULL
is	NULL
clearly	NULL
responsible	NULL
for	NULL
the	NULL
blockade	NULL
to	NULL
calcium-induced	NULL
signals	NULL
reported	NULL
herein	NULL
,	NULL
the	NULL
use	NULL
of	NULL
cells	NULL
stably	NULL
expressing	NULL
activated	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
in	NULL
these	NULL
studies	NULL
may	NULL
not	NULL
allow	NULL
one	NULL
to	NULL
distinguish	NULL
the	NULL
direct	NULL
effects	NULL
of	NULL
p21	NULL
``	NULL
from	NULL
the	NULL
potential	NULL
indirect	NULL
or	NULL
adaptive	NULL
responses	NULL
to	NULL
the	NULL
long-term	NULL
expression	NULL
of	NULL
an	NULL
activated	NULL
ras	NULL
gene	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
blockade	NULL
of	NULL
the	NULL
calcium	NULL
signal	NULL
on	NULL
later	NULL
events	NULL
in	NULL
activation	NULL
,	NULL
including	NULL
elaboration	NULL
of	NULL
IL-2	NULL
,	NULL
required	NULL
the	NULL
use	NULL
of	NULL
a	NULL
uniform	NULL
population	NULL
of	NULL
T	NULL
lymphocytes	NULL
stably	NULL
expressing	NULL
activated	NULL
p21	NULL
``	NULL
.	NULL

However	NULL
,	NULL
some	NULL
adaption	NULL
to	NULL
chronic	NULL
expression	NULL
of	NULL
activated	NULL
Ras	NULL
likely	NULL
occurs	NULL
at	NULL
a	NULL
number	NULL
of	NULL
levels	NULL
within	NULL
the	NULL
cell	NULL
.	NULL

The	NULL
basal	NULL
levels	NULL
of	NULL
Ras	NULL
activity	NULL
in	NULL
the	NULL
v-ras-transfected	NULL
cells	NULL
studied	NULL
here	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
p21	NULL
``	NULL
``	NULL
-bound	NULL
GTP/GDP	NULL
ratios	NULL
,	NULL
were	NULL
of	NULL
a	NULL
magnitude	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
after	NULL
stimulation	NULL
of	NULL
the	NULL
control	NULL
Jurkat	NULL
cells	NULL
.	NULL

Feedback	NULL
mechanisms	NULL
that	NULL
control	NULL
Ras	NULL
function	NULL
may	NULL
be	NULL
constitutively	NULL
upregulated	NULL
during	NULL
chronic	NULL
expression	NULL
or	NULL
may	NULL
no	NULL
longer	NULL
respond	NULL
in	NULL
the	NULL
same	NULL
way	NULL
as	NULL
during	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Ca++	NULL
Ca**+	NULL
CaM	NULL
e	NULL
--	NULL
*Ras	NULL
*	NULL
Â¥	NULL
a	NULL
-L	NULL
1s	NULL
_|	NULL
:	NULL
egr-	NULL
1	NULL
-L	NULL
``	NULL
ofos	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Schematic	NULL
model	NULL
of	NULL
the	NULL
potential	NULL
regulatory	NULL
roles	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
in	NULL
the	NULL
calcium	NULL
signaling	NULL
pathway	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

CaM	NULL
,	NULL
calmodulin	NULL
;	NULL
CN	NULL
,	NULL
calcineurin	NULL
;	NULL
arrows	NULL
,	NULL
stimulation	NULL
;	NULL
double	NULL
bars	NULL
with	NULL
minus	NULL
signs	NULL
,	NULL
inhibition	NULL
.	NULL

&	NULL
_I	NULL
:	NULL
c.jun	NULL
transient	NULL
Ras	NULL
activation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
MAP	NULL
kinase	NULL
is	NULL
induced	NULL
manyfold	NULL
by	NULL
acute	NULL
expression	NULL
of	NULL
activated	NULL
Ras	NULL
,	NULL
but	NULL
longer-term	NULL
Ras	NULL
expression	NULL
results	NULL
in	NULL
a	NULL
more	NULL
modest	NULL
level	NULL
of	NULL
chronic	NULL
activation	NULL
of	NULL
this	NULL
kinase	NULL
activity	NULL
(	NULL
26	NULL
)	NULL
,	NULL
to	NULL
just	NULL
the	NULL
level	NULL
of	NULL
magnitude	NULL
we	NULL
observed	NULL
in	NULL
the	NULL
lymphoid	NULL
cells	NULL
studied	NULL
in	NULL
this	NULL
report	NULL
.	NULL

Under	NULL
unstimulated	NULL
conditions	NULL
,	NULL
however	NULL
,	NULL
there	NULL
were	NULL
no	NULL
differences	NULL
in	NULL
terms	NULL
of	NULL
IE	NULL
gene	NULL
expression	NULL
,	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
activation-related	NULL
transcriptional	NULL
factors	NULL
or	NULL
in	NULL
calcium	NULL
fluctuations	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
activated	NULL
Ras	NULL
,	NULL
in	NULL
these	NULL
Jurkat	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
signaling	NULL
pathways	NULL
examined	NULL
here	NULL
were	NULL
not	NULL
generally	NULL
deranged	NULL
by	NULL
activated	NULL
p21	NULL
``	NULL
.	NULL

It	NULL
was	NULL
similarly	NULL
possible	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
responsiveness	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
we	NULL
report	NULL
here	NULL
in	NULL
the	NULL
cells	NULL
expressing	NULL
v-Ras	NULL
was	NULL
an	NULL
adaptive	NULL
response	NULL
in	NULL
the	NULL
endogenous	NULL
regulation	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
rather	NULL
than	NULL
an	NULL
effect	NULL
of	NULL
Ras	NULL
expression	NULL
.	NULL

The	NULL
transient-transfection	NULL
studies	NULL
we	NULL
employed	NULL
using	NULL
the	NULL
fos	NULL
promoter-CAT	NULL
reporter	NULL
vector	NULL
,	NULL
however	NULL
,	NULL
demonstrated	NULL
that	NULL
exogenously	NULL
introduced	NULL
genes	NULL
were	NULL
similarly	NULL
suppressed	NULL
.	NULL

Whether	NULL
the	NULL
mechanistic	NULL
effects	NULL
on	NULL
calcium	NULL
signaling	NULL
we	NULL
observed	NULL
during	NULL
long-term	NULL
expression	NULL
of	NULL
Ras	NULL
also	NULL
occur	NULL
during	NULL
transient	NULL
activation	NULL
of	NULL
Ras	NULL
during	NULL
,	NULL
for	NULL
example	NULL
,	NULL
mitogenic	NULL
stimulation	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Our	NULL
results	NULL
demonstrating	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
Ras	NULL
in	NULL
the	NULL
modification	NULL
of	NULL
activation	NULL
signals	NULL
may	NULL
initially	NULL
appear	NULL
paradoxical	NULL
,	NULL
given	NULL
the	NULL
established	NULL
functions	NULL
of	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
in	NULL
a	NULL
number	NULL
of	NULL
pathways	NULL
that	NULL
promote	NULL
cell	NULL
survival	NULL
,	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
or	NULL
some	NULL
combination	NULL
of	NULL
these	NULL
processes	NULL
.	NULL

Yet	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
by	NULL
us	NULL
and	NULL
other	NULL
groups	NULL
that	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
not	NULL
only	NULL
regulates	NULL
cell	NULL
growth	NULL
but	NULL
also	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
lymphoid	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
cells	NULL
of	NULL
other	NULL
lineages	NULL
,	NULL
depending	NULL
upon	NULL
its	NULL
interaction	NULL
with	NULL
other	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
PKC	NULL
,	NULL
Bcl-2	NULL
,	NULL
and	NULL
ceramide	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
p21	NULL
'	NULL
``	NULL
relays	NULL
information	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
extracellular	NULL
signals	NULL
across	NULL
the	NULL
membrane	NULL
to	NULL
regulate	NULL
many	NULL
different	NULL
pathways	NULL
.	NULL

Ras	NULL
appears	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
dual	NULL
functions	NULL
in	NULL
modifying	NULL
such	NULL
signals	NULL
.	NULL

In	NULL
one	NULL
case	NULL
,	NULL
the	NULL
positive	NULL
(	NULL
activation	NULL
)	NULL
signals	NULL
delivered	NULL
by	NULL
Ras	NULL
may	NULL
regulate	NULL
the	NULL
preexisting	NULL
components	NULL
,	NULL
such	NULL
as	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
(	NULL
74	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

How	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
ever	NULL
,	NULL
the	NULL
negative	NULL
modulation	NULL
may	NULL
prevent	NULL
overproduction	NULL
of	NULL
,	NULL
or	NULL
efficiently	NULL
terminate	NULL
the	NULL
activity	NULL
of	NULL
,	NULL
newly	NULL
synthesized	NULL
components	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
and	NULL
keep	NULL
cells	NULL
capable	NULL
of	NULL
responding	NULL
to	NULL
further	NULL
stimuli	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
whereby	NULL
p21	NULL
``	NULL
``	NULL
,	NULL
as	NULL
a	NULL
central	NULL
regulator	NULL
of	NULL
diverse	NULL
biological	NULL
processes	NULL
,	NULL
recognizes	NULL
,	NULL
distinguishes	NULL
,	NULL
integrates	NULL
,	NULL
and	NULL
modifies	NULL
signals	NULL
before	NULL
transducing	NULL
to	NULL
downstream	NULL
molecules	NULL
,	NULL
subsequently	NULL
leading	NULL
to	NULL
cell	NULL
growth	NULL
,	NULL
anergy	NULL
,	NULL
or	NULL
apoptosis	NULL
,	NULL
are	NULL
not	NULL
yet	NULL
established	NULL
.	NULL

Further	NULL
investigation	NULL
of	NULL
the	NULL
switch	NULL
points	NULL
for	NULL
Ras	NULL
to	NULL
direct	NULL
signaling	NULL
along	NULL
such	NULL
diverse	NULL
pathways	NULL
will	NULL
further	NULL
elucidate	NULL
the	NULL
nature	NULL
of	NULL
this	NULL
molecule	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Rolf	NULL
Muller	NULL
for	NULL
providing	NULL
c-fos	NULL
promoter	NULL
plasmids	NULL
,	NULL
Cox	NULL
Terhorst	NULL
for	NULL
providing	NULL
anti-CD3y	NULL
antibody	NULL
,	NULL
Vikas	NULL
Sukhatme	NULL
for	NULL
the	NULL
egr-1	NULL
probe	NULL
,	NULL
Edward	NULL
Scolnick	NULL
for	NULL
the	NULL
pHI1	NULL
clone	NULL
,	NULL
and	NULL
Sandoz	NULL
Pharmaceuticals	NULL
for	NULL
CsA	NULL
.	NULL

We	NULL
thank	NULL
Jackson	NULL
Gibbs	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
research	NULL
grant	NULL
CA50459	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
(	NULL
D.V.F	NULL
.	NULL
)	NULL

.	NULL

C.Y.C	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
Cardiovascular	NULL
Biology	NULL
Training	NULL
Grant	NULL
from	NULL
the	NULL
National	NULL
Heart	NULL
,	NULL
Lung	NULL
and	NULL
Blood	NULL
Institute	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Acres	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
P.	NULL
J.	NULL
Conlon	NULL
,	NULL
D.	NULL
Y.	NULL
Mochizuki	NULL
,	NULL
and	NULL
B.	NULL
Gallis	NULL
.	NULL

1986	NULL
.	NULL

Rapid	NULL
phosphorylation	NULL
and	NULL
modulation	NULL
of	NULL
the	NULL
T4	NULL
antigen	NULL
on	NULL
cloned	NULL
helper	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
or	NULL
antigen	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261:16210-16216	NULL
.	NULL

2	NULL
.	NULL

Alexander	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
J.	NULL
M.	NULL
Hexham	NULL
,	NULL
S.	NULL
C.	NULL
Lucas	NULL
,	NULL
J.	NULL
D.	NULL
Graves	NULL
,	NULL
D.	NULL
A.	NULL
Cantrell	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Crumpton	NULL
,	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
protein	NULL
kinase	NULL
C	NULL
pseudosubstrate	NULL
peptide	NULL
inhibits	NULL
phosphorylation	NULL
of	NULL
the	NULL
CD3	NULL
antigen	NULL
in	NULL
streptolysin-O-permeabilized	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

260:893-901	NULL
.	NULL

3	NULL
.	NULL

Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
rapid	NULL
micropreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
limiting	NULL
numbers	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:2499-2503	NULL
.	NULL

4	NULL
.	NULL

Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Klausner	NULL
.	NULL

1990	NULL
.	NULL

Genetic	NULL
and	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:139-167	NULL
.	NULL

5	NULL
.	NULL

Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Telford	NULL
.	NULL

1993	NULL
.	NULL

Calcium	NULL
dependent	NULL
activation	NULL
of	NULL
the	NULL
NF-AT	NULL
transcription	NULL
factor	NULL
by	NULL
p56	NULL
``	NULL
**	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

323:233-235	NULL
.	NULL

6	NULL
.	NULL

Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Telford	NULL
.	NULL

1993	NULL
.	NULL

Calcium-dependent	NULL
cyclosporin	NULL
A-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
p59	NULL
%	NULL
``	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:8406-8408	NULL
.	NULL

7	NULL
.	NULL

Blenis	NULL
,	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

Signal	NULL
transduction	NULL
via	NULL
the	NULL
MAP	NULL
kinases	NULL
:	NULL
proceed	NULL
at	NULL
your	NULL
own	NULL
RSK	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:5889-5892	NULL
.	NULL

8	NULL
.	NULL

Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
L.	NULL
H.	NULL
K.	NULL
Defize	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
J.	NULL
R.	NULL
Woodgett	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
T.	NULL
Hunter	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
decreases	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
at	NULL
sites	NULL
that	NULL
negatively	NULL
regulate	NULL
its	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Cell	NULL
64:573-584	NULL
.	NULL

9	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Davies	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Crumpton	NULL
,	NULL
.	NULL

1985	NULL
.	NULL

Activators	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
down-regulate	NULL
and	NULL
phosphorylate	NULL
the	NULL
T3/T-cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:8158-8163	NULL
.	NULL

10	NULL
.	NULL

Chen	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1995	NULL
.	NULL

Direction	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
generated	NULL
signals	NULL
towards	NULL
cell	NULL
growth	NULL
or	NULL
apoptosis	NULL
is	NULL
determined	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
Bcl-2	NULL
.	NULL

Oncogene	NULL
11:1487-1498	NULL
.	NULL

11	NULL
.	NULL

Chen	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
,	NULL
1996	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Bcl-2	NULL
protein	NULL
and	NULL
association	NULL
with	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
in	NULL
Ras-induced	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:2376-2379	NULL
.	NULL

11a.Chen	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
L.	NULL
W.	NULL
Forman	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

Multiple	NULL
targets	NULL
of	NULL
cyclosporin	NULL
A	NULL
in	NULL
suppression	NULL
of	NULL
IL-2	NULL
induction	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Submitted	NULL
for	NULL
publi-cation	NULL
.	NULL

11b.Chen	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

12	NULL
.	NULL

Chen	NULL
,	NULL
R.-H.	NULL
,	NULL
C.	NULL
Sarnecki	NULL
,	NULL
and	NULL
J.	NULL
Blenis	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
localization	NULL
and	NULL
regulation	NULL
of	NULL
erk-	NULL
and	NULL
rdk-encoded	NULL
protein	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:915-927	NULL
.	NULL

13	NULL
.	NULL

Chung	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
J.	NULL
Kuo	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
J.	NULL
Blenis	NULL
.	NULL

1992	NULL
.	NULL

Rapamycin-FKBP	NULL
specifically	NULL
blocks	NULL
growth-dependent	NULL
activation	NULL
of	NULL
and	NULL
signaling	NULL
by	NULL
the	NULL
70	NULL
kd	NULL
S6	NULL
protein	NULL
kinases	NULL
.	NULL

Cell	NULL
69:1227-1236	NULL
.	NULL

14	NULL
.	NULL

Clipstone	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
key	NULL
signaling	NULL
enzyme	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:695-697	NULL
.	NULL

15	NULL
.	NULL

Coussens	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Parker	NULL
,	NULL
L.	NULL
Rhee	NULL
,	NULL
T.	NULL
L.	NULL
Yang-Feng	NULL
,	NULL
M.	NULL
D.	NULL
Waterfield	NULL
,	NULL
U.	NULL
Franck	NULL
,	NULL
and	NULL
A.	NULL
Ullrich	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
,	NULL
distinct	NULL
forms	NULL
of	NULL
bovine	NULL
and	NULL
human	NULL
protein	NULL
kinase	NULL
C	NULL
suggest	NULL
diversity	NULL
in	NULL
cellular	NULL
signaling	NULL
pathways	NULL
.	NULL

Science	NULL
233:859-866	NULL
.	NULL

16	NULL
.	NULL

Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Franza	NULL
.	NULL

1988	NULL
.	NULL

Fos	NULL
and	NULL
Jun	NULL
:	NULL
the	NULL
AP-1	NULL
connection	NULL
.	NULL

Cell	NULL
55:395-396	NULL
.	NULL

17	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
1989	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Science	NULL
243:355-361	NULL
.	NULL

NEGATIVE	NULL
REGULATION	NULL
OF	NULL
IE	NULL
GENE	NULL
EXPRESSION	NULL
BY	NULL
Ras	NULL
6591	NULL
18	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
L.-H.	NULL
Wu	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
T.	NULL
Deng	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

JNK1	NULL
:	NULL
a	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
76:1025-1037	NULL
.	NULL

19	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Graves	NULL
,	NULL
P.	NULL
H.	NULL
Warne	NULL
,	NULL
S.	NULL
Rayter	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
upon	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:719-723	NULL
.	NULL

20	NULL
.	NULL

Faller	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
L.	NULL
J.	NULL
Mundschau	NULL
,	NULL
L.	NULL
W.	NULL
Forman	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Quinones	NULL
.	NULL

1994.	NULL
v-mos	NULL
suppresses	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
(	NULL
PDGF	NULL
)	NULL
type-B	NULL
receptor	NULL
autophosphorylation	NULL
and	NULL
inhibits	NULL
PDGF-BB-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:5022-5029	NULL
.	NULL

21	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
B.	NULL
Vogelstein	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132:6-13	NULL
.	NULL

22	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
B.	NULL
Corthesy	NULL
,	NULL
R.	NULL
J.	NULL
Bram	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:803-806	NULL
.	NULL

23	NULL
.	NULL

Frank	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
Niklinska	NULL
,	NULL
D.	NULL
G.	NULL
Orloff	NULL
,	NULL
M.	NULL
Mevcep	NULL
,	NULL
J.	NULL
D.	NULL
Ashwell	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Klausner	NULL
.	NULL

1990	NULL
.	NULL

Structural	NULL
mutations	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
{	NULL
and	NULL
its	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
249:174-177	NULL
.	NULL

24	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
D.	NULL
Straus	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1993	NULL
.	NULL

Signal	NULL
transduction	NULL
events	NULL
leading	NULL
to	NULL
T-cell	NULL
lymphokine	NULL
gene	NULL
expression	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:357-362	NULL
.	NULL

25	NULL
.	NULL

Friedrich	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
M.	NULL
Gullberg	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
early	NULL
activation	NULL
vs.	NULL
growth	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

18:489-492	NULL
.	NULL

26	NULL
.	NULL

Gallego	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
K.	NULL
Gupta	NULL
,	NULL
L.	NULL
E.	NULL
Heasley	NULL
,	NULL
N.	NULL
X.	NULL
Qian	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Johnson	NULL
.	NULL

1992	NULL
.	NULL

Mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
resulting	NULL
from	NULL
selective	NULL
oncogene	NULL
expression	NULL
in	NULL
NIH-3T3	NULL
and	NULL
Rat-la	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7355-7359	NULL
.	NULL

27	NULL
.	NULL

Gonzalez	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
A.	NULL
Seth	NULL
,	NULL
D.	NULL
L.	NULL
Raden	NULL
,	NULL
D.	NULL
S.	NULL
Bowman	NULL
,	NULL
F.	NULL
S.	NULL
Fay	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1993	NULL
.	NULL

Serum-induced	NULL
translocation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
ruffling	NULL
membrane	NULL
and	NULL
the	NULL
nucleus	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

122:1089-1101	NULL
.	NULL

28	NULL
.	NULL

Graves	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
proteins	NULL
in	NULL
antigen	NULL
receptor/CD3	NULL
antigen	NULL
coupling	NULL
to	NULL
phospholipase	NULL
C.	NULL
J.	NULL
Immunol	NULL
.	NULL

146:2102-2107	NULL
.	NULL

29	NULL
.	NULL

Graves	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
M.	NULL
Izquierdo-Pastor	NULL
,	NULL
S.	NULL
Rayter	NULL
,	NULL
P.	NULL
H.	NULL
Warne	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
growth	NULL
factor	NULL
IL-2	NULL
activates	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
proteins	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:2417-2422	NULL
.	NULL

30	NULL
.	NULL

Graves	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
S.	NULL
C.	NULL
Lucas	NULL
,	NULL
D.	NULL
R.	NULL
Alexander	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1990	NULL
.	NULL

Guanine	NULL
nucleotide	NULL
regulation	NULL
of	NULL
inositol	NULL
phospholipid	NULL
hydrolysis	NULL
and	NULL
CD3-antigen	NULL
phosphorylation	NULL
in	NULL
permeabilized	NULL
T	NULL
lymphocytes	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

265	NULL
:	NULL
407-413	NULL
.	NULL

31	NULL
.	NULL

Gulbins	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Bi	NULL
tte	NULL
,	NULL
A.	NULL
Mahboubi	NULL
,	NULL
S.	NULL
Martin	NULL
,	NULL
W.	NULL
Nishioka	NULL
,	NULL
T.	NULL
Brun-ner	NULL
,	NULL
G.	NULL
Baier	NULL
,	NULL
G.	NULL
Baier-Bitterlich	NULL
,	NULL
C.	NULL
Byrd	NULL
,	NULL
F.	NULL
Lang	NULL
,	NULL
R.	NULL
Kolesnick	NULL
,	NULL
A.	NULL
Altman	NULL
,	NULL
and	NULL
D.	NULL
Green	NULL
.	NULL

1995	NULL
.	NULL

Fas-induced	NULL
apoptosis	NULL
is	NULL
mediated	NULL
via	NULL
a	NULL
ceramide-initiated	NULL
Ras	NULL
signaling	NULL
pathway	NULL
.	NULL

Immunity	NULL
2:341-351	NULL
.	NULL

32	NULL
.	NULL

Hayes	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
A.	NULL
M.	NULL
Kitchen	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Cochran	NULL
.	NULL

1987	NULL
.	NULL

Inducible	NULL
binding	NULL
of	NULL
a	NULL
factor	NULL
to	NULL
the	NULL
c-fos	NULL
regulatory	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:1272-1276	NULL
.	NULL

33	NULL
.	NULL

Hibi	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
B.	NULL
H.	NULL
Lin	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
A.	NULL
Minden	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
oncoprotein-	NULL
and	NULL
UV-responsive	NULL
protein	NULL
kinase	NULL
that	NULL
binds	NULL
and	NULL
potentiates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2135-2148	NULL
.	NULL

34	NULL
.	NULL

Izquierdo	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
S.	NULL
J.	NULL
Leevers	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
``	NULL
couples	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
2	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1199-1208	NULL
.	NULL

35	NULL
.	NULL

Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
D.	NULL
Graves	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
regulation	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
:	NULL
evidence	NULL
that	NULL
two	NULL
p21	NULL
``	NULL
``	NULL
regulatory	NULL
pathways	NULL
coexist	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3305-3312	NULL
.	NULL

36	NULL
.	NULL

Jain	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
A.	NULL
J.	NULL
Sinskey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
at	NULL
-150	NULL
bp	NULL
,	NULL
but	NULL
not	NULL
the	NULL
NF-kB	NULL
site	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
represent	NULL
the	NULL
major	NULL
target	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:853-862	NULL
.	NULL

37	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:801-804	NULL
.	NULL

38	NULL
.	NULL

Kallunki	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
I	NULL
TsigeIny	NULL
,	NULL
H.	NULL
K.	NULL
Kluss	NULL
,	NULL
B.	NULL
Derijard	NULL
,	NULL
G.	NULL
Moore	NULL
,	NULL
R.	NULL
Davis	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1994	NULL
.	NULL

JNK2	NULL
contains	NULL
a	NULL
specificity-determining	NULL
region	NULL
responsible	NULL
for	NULL
efficient	NULL
c-Jun	NULL
binding	NULL
and	NULL
phosphorylation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2996-3007	NULL
.	NULL

39	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
B.	NULL
Beverly	NULL
,	NULL
A.-C.	NULL
Tran	NULL
,	NULL
K.	NULL
Brorson	NULL
,	NULL
R.	NULL
H.	NULL
Schwartz	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
by	NULL
AP-1	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
of	NULL
T	NULL
cell	NULL
clonal	NULL
anergy	NULL
.	NULL

Science	NULL
257:1134-1138	NULL
.	NULL

40	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
The	NULL
regulation	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

1995	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:16483-16486	NULL
.	NULL

41	NULL
.	NULL

Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1991	NULL
.	NULL

Transcription	NULL
factor	NULL
interactions	NULL
:	NULL
basics	NULL
on	NULL
zippers	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Struct	NULL
.	NULL

Biol	NULL
.	NULL

1:71-79	NULL
.	NULL

42	NULL
.	NULL

Knopf	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
M.	NULL
Lee	NULL
,	NULL
L.	NULL
A.	NULL
Sultzman	NULL
,	NULL
R.	NULL
W.	NULL
Kriz	NULL
,	NULL
G.	NULL
R.	NULL
Loomis	NULL
,	NULL
R.	NULL
M.	NULL
Hewich	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Bell	NULL
.	NULL

1986	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
multiple	NULL
protein	NULL
kinase	NULL
C	NULL
cDNAs	NULL
.	NULL

Cell	NULL
46:491-502	NULL
.	NULL

43	NULL
.	NULL

Koka	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
A.	NULL
van	NULL
de	NULL
Mark	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1991	NULL
.	NULL

Trans-activation	NULL
of	NULL
genes	NULL
encoding	NULL
activation-associated	NULL
human	NULL
T	NULL
lymphocyte	NULL
surface	NULL
proteins	NULL
by	NULL
murine	NULL
retroviral	NULL
sequences	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:2417-2425	NULL
.	NULL

6592	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

CHEN	NULL
ET	NULL
AL	NULL
.	NULL

Koning	NULL
,	NULL
F.	NULL
1991	NULL
.	NULL

Lymphocyte	NULL
antigen	NULL
receptors	NULL
:	NULL
a	NULL
common	NULL
design	NULL
?	NULL

Immunol	NULL
.	NULL

Today	NULL
12:100-101	NULL
.	NULL

Kronke	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Green	NULL
.	NULL

1985	NULL
.	NULL

Sequential	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
human	NULL
T	NULL
lymphocyte	NULL
growth	NULL
and	NULL
differen-tiation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

161:1593-1598	NULL
.	NULL

Leevers	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Marshall	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
,	NULL
ERK2	NULL
,	NULL
by	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
oncoproteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:569-572	NULL
.	NULL

Lemaire	NULL
,	NULL
P.	NULL
,	NULL
O.	NULL
Revelant	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
P.	NULL
Charnay	NULL
.	NULL

1988	NULL
.	NULL

Two	NULL
mouse	NULL
genes	NULL
encoding	NULL
potential	NULL
transcription	NULL
factors	NULL
with	NULL
identical	NULL
DNA-binding	NULL
domains	NULL
are	NULL
activated	NULL
by	NULL
growth	NULL
factors	NULL
in	NULL
cultured	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4691-4695	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
Â«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Lenormand	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Sardet	NULL
,	NULL
G.	NULL
Pages	NULL
,	NULL
G.	NULL
'Allemain	NULL
,	NULL
A.	NULL
Brunet	NULL
,	NULL
and	NULL
J.	NULL
Pouyssegur	NULL
.	NULL

1993	NULL
.	NULL

Growth	NULL
factors	NULL
induce	NULL
nuclear	NULL
translocation	NULL
of	NULL
MAP	NULL
kinases	NULL
(	NULL
p42	NULL
``	NULL
``	NULL
**	NULL
and	NULL
p44	NULL
'	NULL
``	NULL
**	NULL
)	NULL
but	NULL
not	NULL
of	NULL
their	NULL
activator	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
p56	NULL
``	NULL
*	NULL
)	NULL
in	NULL
fibroblasts	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

122:1079-1088	NULL
.	NULL

Lim	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
B.	NULL
C.	NULL
Varnum	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Herschman	NULL
.	NULL

1987	NULL
.	NULL

Cloning	NULL
of	NULL
tetra-decanoyl	NULL
phorbol	NULL
ester-induced	NULL
``	NULL
primary	NULL
response	NULL
``	NULL
sequences	NULL
and	NULL
their	NULL
expression	NULL
in	NULL
density-arrested	NULL
Swiss	NULL
3T3	NULL
cells	NULL
and	NULL
a	NULL
TPA	NULL
nonproliferative	NULL
variant	NULL
.	NULL

Oncogene	NULL
1:263-270	NULL
.	NULL

Lowy	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Willumsen	NULL
.	NULL

1993	NULL
.	NULL

Function	NULL
and	NULL
regulation	NULL
of	NULL
Ras	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

62:851-891	NULL
.	NULL

Lucas	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Marais	NULL
,	NULL
J.	NULL
D.	NULL
Graves	NULL
,	NULL
K.	NULL
Alexander	NULL
,	NULL
P.	NULL
Parker	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1990	NULL
.	NULL

Heterogeneity	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
expression	NULL
and	NULL
regulation	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

260:53-56	NULL
.	NULL

Marshall	NULL
,	NULL
M.	NULL
S.	NULL
1993	NULL
.	NULL

The	NULL
effector	NULL
interactions	NULL
of	NULL
p21	NULL
(	NULL
ras	NULL
)	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

18:250-254	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Perrino	NULL
,	NULL
T.	NULL
R.	NULL
Soderling	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

NF-AT	NULL
,	NULL
,	NULL
,	NULL
a	NULL
T	NULL
lymphocyte	NULL
DNA-binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
target	NULL
for	NULL
calcineurin	NULL
and	NULL
immunosuppressive	NULL
drugs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:3747-3752	NULL
.	NULL

McMahon	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
primary	NULL
response	NULL
genes	NULL
in	NULL
generating	NULL
cellular	NULL
responses	NULL
to	NULL
growth	NULL
factors	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

6:2707-2715	NULL
.	NULL

McMahon	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
ternary	NULL
complex	NULL
factor-dependent	NULL
mechanism	NULL
mediates	NULL
induction	NULL
of	NULL
egr-7	NULL
through	NULL
selective	NULL
serum	NULL
response	NULL
elements	NULL
following	NULL
antigen	NULL
receptor	NULL
cross-linking	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1086-1093	NULL
.	NULL

Miranti	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
D.	NULL
D.	NULL
Ginty	NULL
,	NULL
G.	NULL
Huang	NULL
,	NULL
T.	NULL
Chatila	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1995	NULL
.	NULL

Calcium	NULL
activates	NULL
serum	NULL
response	NULL
factor-dependent	NULL
transcription	NULL
by	NULL
a	NULL
Ras-	NULL
and	NULL
Elk-1-independent	NULL
mechanism	NULL
that	NULL
involves	NULL
a	NULL
Ca	NULL
``	NULL
*/calmodulin-dependent	NULL
kinase	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3672-3684	NULL
.	NULL

Misra	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
A.	NULL
Bonni	NULL
,	NULL
C.	NULL
K.	NULL
Miranti	NULL
,	NULL
V.	NULL
M.	NULL
Rivera	NULL
,	NULL
M.	NULL
Sheng	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1994	NULL
.	NULL

L-type	NULL
voltage-sensitive	NULL
calcium	NULL
channel	NULL
activation	NULL
stimulates	NULL
gene	NULL
expression	NULL
by	NULL
a	NULL
serum	NULL
response	NULL
factor-dependent	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:25483-25493	NULL
.	NULL

Mundschau	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1992	NULL
.	NULL

Oncogenic	NULL
ras	NULL
induces	NULL
an	NULL
inhibitor	NULL
of	NULL
double-stranded	NULL
RNA-dependent	NULL
eukaryotic	NULL
initiation	NULL
factor-2	NULL
Â«	NULL
-kinase	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:23092-23098	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
molecular	NULL
heterogeneity	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
its	NULL
implications	NULL
for	NULL
cellular	NULL
regulation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:661-665	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
K.	NULL
S.	NULL
Ullman	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid	NULL
specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

O'Neill	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
I.	NULL
Rebay	NULL
,	NULL
R.	NULL
Tjian	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Rubin	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
two	NULL
Ets-related	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
Drosophila	NULL
eye	NULL
development	NULL
are	NULL
modulated	NULL
by	NULL
the	NULL
Ras/MAPK	NULL
pathway	NULL
.	NULL

Cell	NULL
78:137-147	NULL
.	NULL

Ono	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
Kwokawa	NULL
,	NULL
U.	NULL
Kawahara	NULL
,	NULL
O.	NULL
Nishimura	NULL
,	NULL
R.	NULL
Marumoto	NULL
,	NULL
K.	NULL
Iga-rashi	NULL
,	NULL
Y.	NULL
Sugiro	NULL
,	NULL
T.	NULL
Kikkawa	NULL
,	NULL
K.	NULL
Ogita	NULL
,	NULL
and	NULL
Y.	NULL
Nishizuka	NULL
.	NULL

1986	NULL
.	NULL

Cloning	NULL
of	NULL
rat	NULL
brain	NULL
protein	NULL
kinase	NULL
C	NULL
complementary	NULL
DNA	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

203:111-115	NULL
.	NULL

Parker	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
L.	NULL
Coussens	NULL
,	NULL
N.	NULL
Totty	NULL
,	NULL
L.	NULL
Rhee	NULL
,	NULL
S.	NULL
Young	NULL
,	NULL
E.	NULL
Chen	NULL
,	NULL
M.	NULL
D.	NULL
Waterfield	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
A.	NULL
Ullrich	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
complete	NULL
primary	NULL
structure	NULL
of	NULL
protein	NULL
kinase	NULL
C-the	NULL
major	NULL
phorbol	NULL
ester	NULL
receptor	NULL
.	NULL

Science	NULL
233:853-859	NULL
.	NULL

Rake	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
M.	NULL
A.	NULL
Quinones	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
platelet-derived	NULL
growth	NULL
factor-mediated	NULL
signal	NULL
transduction	NULL
by	NULL
transforming	NULL
ras	NULL
.	NULL

Suppression	NULL
of	NULL
receptor	NULL
autophosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:5348-5352	NULL
.	NULL

Rebay	NULL
,	NULL
L	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Rubin	NULL
.	NULL

1995	NULL
.	NULL

Yan	NULL
functions	NULL
as	NULL
a	NULL
general	NULL
inhibitor	NULL
of	NULL
differentiation	NULL
and	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
Ras1/MAPK	NULL
pathway	NULL
.	NULL

Cell	NULL
81:857-866	NULL
.	NULL

Rivera	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
M.	NULL
Sheng	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
inner	NULL
core	NULL
of	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
mediates	NULL
both	NULL
the	NULL
rapid	NULL
induction	NULL
and	NULL
subsequent	NULL
68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

repression	NULL
of	NULL
c-fos	NULL
transcription	NULL
following	NULL
serum	NULL
stimulation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:255-268	NULL
.	NULL

Roden	NULL
,	NULL
R.	NULL
B.	NULL
S.	NULL
,	NULL
Y.	NULL
Shacharhill	NULL
,	NULL
S.	NULL
C.	NULL
Cosulich	NULL
,	NULL
T.	NULL
R.	NULL
Hesketh	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Metcalfe	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
common	NULL
requirement	NULL
for	NULL
p21	NULL
(	NULL
ras	NULL
)	NULL
function	NULL
in	NULL
the	NULL
mitogenic	NULL
signaling	NULL
pathways	NULL
of	NULL
Swiss	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

4:957-964	NULL
.	NULL

Rosen	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
D.	NULL
D.	NULL
Ginty	NULL
,	NULL
M.	NULL
J.	NULL
Weber	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1994	NULL
.	NULL

Membrane	NULL
depolarization	NULL
and	NULL
calcium	NULL
influx	NULL
stimulate	NULL
MEK	NULL
and	NULL
MAP	NULL
kinase	NULL
via	NULL
activation	NULL
of	NULL
Ras	NULL
.	NULL

Neuron	NULL
12:1207-1221	NULL
.	NULL

Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
J.	NULL
Harford	NULL
,	NULL
R.	NULL
H.	NULL
Schwartz	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Klausner	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
20-kDa	NULL
protein	NULL
associated	NULL
with	NULL
the	NULL
murine	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
is	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
by	NULL
antigen	NULL
or	NULL
concanavalin	NULL
A.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:1969-1973	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205	NULL
.	NULL

Sheng	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
T.	NULL
Dougan	NULL
,	NULL
G.	NULL
McFadden	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1988	NULL
.	NULL

Calcium	NULL
and	NULL
growth	NULL
factor	NULL
pathways	NULL
of	NULL
c-fos	NULL
transcriptional	NULL
activation	NULL
require	NULL
distinct	NULL
upstream	NULL
regulatory	NULL
sequences	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:2787-2796	NULL
.	NULL

Sheng	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
c-fos	NULL
and	NULL
other	NULL
immediate	NULL
carly	NULL
genes	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

Neuron	NULL
4:477-485	NULL
.	NULL

Stacey	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
T.	NULL
Watson	NULL
,	NULL
H.-F.	NULL
Kung	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1987	NULL
.	NULL

Microinjection	NULL
of	NULL
transforming	NULL
ras	NULL
protein	NULL
induces	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:523-527	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727-736	NULL
.	NULL

Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
L.	NULL
C.	NULL
Chang	NULL
,	NULL
C.-H.	NULL
Tsai-Morris	NULL
,	NULL
D.	NULL
Stamenkovich	NULL
,	NULL
P.	NULL
C.	NULL
P.	NULL
Ferreira	NULL
,	NULL
D.	NULL
R.	NULL
Cohen	NULL
,	NULL
S.	NULL
A.	NULL
Edwards	NULL
,	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
M.	NULL
M.	NULL
LeBeau	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Adamson	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
zinc	NULL
finger-encoding	NULL
gene	NULL
co-regulated	NULL
with	NULL
c-fos	NULL
during	NULL
growth	NULL
and	NULL
differentiation	NULL
,	NULL
and	NULL
after	NULL
cellular	NULL
depolariza-tion	NULL
.	NULL

Cell	NULL
53:37-43	NULL
.	NULL

Thomas	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
M.	NULL
DeMarco	NULL
,	NULL
G.	NULL
D'Arcangelo	NULL
,	NULL
S.	NULL
Halegoua	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Brugge	NULL
.	NULL

1992	NULL
.	NULL

Ras	NULL
is	NULL
essential	NULL
for	NULL
nerve	NULL
growth	NULL
factor	NULL
and	NULL
phorbol	NULL
ester-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
MAP	NULL
kinases	NULL
.	NULL

Cell	NULL
68:1031-1040	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1990	NULL
.	NULL

The	NULL
SRE	NULL
:	NULL
a	NULL
growth	NULL
factor	NULL
responsive	NULL
transcriptional	NULL
regulator	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

1147-58	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Northrop	NULL
,	NULL
C.	NULL
L	NULL
Verweij	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1990	NULL
.	NULL

Transmission	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
genes	NULL
responsible	NULL
for	NULL
cell	NULL
proliferation	NULL
and	NULL
immune	NULL
function	NULL
:	NULL
the	NULL
missing	NULL
link	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:421-452	NULL
.	NULL

Vaziri	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1995	NULL
.	NULL

Repression	NULL
of	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
B-receptor	NULL
expression	NULL
by	NULL
mitogenic	NULL
growth	NULL
factors	NULL
and	NULL
transforming	NULL
oncogenes	NULL
in	NULL
murine	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1244-1253	NULL
.	NULL

Vries-Smits	NULL
,	NULL
A.	NULL
M.	NULL
M.	NULL
,	NULL
B.	NULL
M.	NULL
T.	NULL
Burgering	NULL
,	NULL
S.	NULL
J.	NULL
Leevers	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Bos	NULL
.	NULL

1992	NULL
.	NULL

Involvement	NULL
of	NULL
p21	NULL
``	NULL
in	NULL
activation	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
2	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:602-605	NULL
.	NULL

Waters	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
K.	NULL
H.	NULL
Holt	NULL
,	NULL
S.	NULL
E.	NULL
Ross	NULL
,	NULL
L.-J	NULL
.	NULL

Syu	NULL
,	NULL
K.-L.	NULL
Guan	NULL
,	NULL
A.	NULL
R.	NULL
Saltiel	NULL
,	NULL
G.	NULL
A.	NULL
Koretzky	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Pessin	NULL
.	NULL

1995	NULL
.	NULL

Desensitization	NULL
of	NULL
Ras	NULL
activation	NULL
by	NULL
a	NULL
feedback	NULL
disassociation	NULL
of	NULL
the	NULL
SOS-Grb2	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
20883-20886	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
L.	NULL
K.	NULL
Tan	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Koretzky	NULL
.	NULL

1991	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

Ser	NULL
.	NULL

3:313-324	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
R.	NULL
L.	NULL
Wiskocil	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Stobo	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
role	NULL
of	NULL
T3	NULL
surface	NULL
molecules	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
two-stimulus	NULL
requirement	NULL
for	NULL
IL-2	NULL
production	NULL
reflects	NULL
events	NULL
occurring	NULL
at	NULL
pre-translational	NULL
level	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

133:123-129	NULL
.	NULL

Weng	NULL
,	NULL
H.	NULL
Q.	NULL
,	NULL
S.	NULL
Y.	NULL
Choi	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Moloney	NULL
leukemia	NULL
retroviral	NULL
long	NULL
terminal	NULL
repeat	NULL
trans-activates	NULL
AP-1-inducible	NULL
genes	NULL
and	NULL
AP-1	NULL
transcription	NULL
factor	NULL
binding	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:13637-13644	NULL
.	NULL

Wood	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
C.	NULL
Sarnecki	NULL
,	NULL
T.	NULL
M.	NULL
Roberts	NULL
,	NULL
and	NULL
J.	NULL
Blenis	NULL
.	NULL

1992	NULL
.	NULL

Ras	NULL
mediates	NULL
nerve	NULL
growth	NULL
factor	NULL
receptor	NULL
modulation	NULL
of	NULL
three	NULL
signal-transducing	NULL
protein	NULL
kinases	NULL
:	NULL
MAP	NULL
kinase	NULL
,	NULL
RAF-1	NULL
,	NULL
and	NULL
RSK	NULL
.	NULL

Cell	NULL
68:1041-1052	NULL
.	NULL

Woodrow	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
N.	NULL
A.	NULL
Clipstone	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
``	NULL
and	NULL
calcineurin	NULL
synergize	NULL
to	NULL
regulate	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1517-1522	NULL
.	NULL

Woodrow	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S.	NULL
Rayter	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
``	NULL
function	NULL
is	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
regulation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:3853-3861	NULL
.	NULL

Zubiaur	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
W.	NULL
Forman	NULL
,	NULL
L.	NULL
L.	NULL
Stice	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
,	NULL
1995	NULL
.	NULL

A	NULL
role	NULL
for	NULL
activated	NULL
p21	NULL
``	NULL
in	NULL
inhibition	NULL
of	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
(	NULL
PDGF	NULL
)	NULL
receptor	NULL
activation	NULL
.	NULL

Oncogene	NULL
12:1213-1222	NULL
.	NULL

